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Abstract 
Intervertebral disc (IVD) disorders and age-related degeneration are believed to 
contribute to low back pain.  There is significant interest in cell-based strategies for 
regenerating the nucleus pulposus (NP) region of the disc; however, few scaffolds have 
been evaluated for their ability to promote or maintain an immature NP cell phenotype.  
Additionally, while cell delivery to the pathological IVD has significant therapeutic 
potential for enhancing NP regeneration, the development of injectable biomaterials that 
retain delivered cells, promote cell survival, and maintain or promote an NP cell 
phenotype in vivo remains a significant challenge.  Previous studies have demonstrated 
NP cell – laminin interactions in the NP region of the IVD that promote cell attachment 
and biosynthesis.  These findings suggest that incorporating laminin ligands into 
biomaterial scaffolds for NP tissue engineering or cell delivery to the disc may be 
beneficial for promoting NP cell survival and phenotype.  In this dissertation, laminin-111 
(LM111) functionalized poly(ethylene glycol) (PEG) hydrogels were developed and 
evaluated as biomaterial scaffolds for cell-based NP regeneration.   
Here, PEG-LM111 conjugates with functional acrylate groups for crosslinking 
were synthesized and characterized to allow for protein coupling to both 
photocrosslinkable and injectable PEG-based biomaterial scaffolds.   PEG-LM111 
conjugates synthesized using low ratios of PEG to LM111 were found support NP cell 
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attachment and signaling in a manner similar to unmodified LM111.  A single PEG-LM111 
conjugate was conjugated to photocrosslinkable PEG-LM111 hydrogels, and studies were 
performed to evaluate the effects of hydrogel formulation on immature NP cell phenotype 
in vitro.   When primary immature porcine NP cells were seeded onto PEG-LM111 
hydrogels of varying stiffnesses, softer LM111 presenting hydrogels were found to 
promote cell clustering and increased levels of sGAG production as compared to stiffer 
LM111 presenting and PEG-only gels.  When cells were encapsulated in 3D gels, hydrogel 
formulation was found to influence NP cell metabolism and expression of proposed NP 
phenotypic markers, with higher expression of N-cadherin and cytokeratin 8 observed for 
cells cultured in softer (<1 kPa) PEG-LM111 hydrogels.    
A novel, injectable PEG-LM111 hydrogel was developed as a biomaterial carrier 
for cell delivery to the IVD.  PEG-LM111 conjugates were crosslinked via a Michael-type 
addition reaction upon the addition of PEG-octoacrylate and PEG-dithiol.  Injectable PEG-
LM111 hydrogel gelation time, mechanical properties, and ability to retain delivered cells 
in the IVD space were evaluated.  Gelation occurred in approximately 20 minutes without 
an initiator, with dynamic shear moduli in the range of 0.9 – 1.4 kPa.  Primary NP cell 
retention in cultured IVD explants was significantly higher over 14 days when cells were 
delivered within a PEG-LM111 hydrogel carrier, as compared to cells in liquid 
suspension.   
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The studies presented in this dissertation demonstrate that soft, LM111 
functionalized hydrogels may promote or maintain the expression of specific markers and 
cell-cell interactions characteristic of an immature NP cell phenotype.  Furthermore, these 
findings suggest that this novel, injectable laminin-functionalized biomaterial may be an 
easy to use and biocompatible carrier for delivering cells to the IVD.  
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1. Introduction  
The human intervertebral disc (IVD) is a fibrocartilaginous tissue that undergoes 
significant changes in cell population, matrix composition and structure during growth, 
and with aging-related degeneration.  IVD disorders including herniation, stenosis, 
spondylolysis, and degeneration resulted in more than 663,000 inpatients stays for back 
surgery or other back disorder treatments in the US in 2008 alone, costing more than $9.5 
billion and making back problems the ninth most expensive condition treated in US 
hospitals [1] .  IVD degeneration is associated with a loss of disc height and hydration, 
diminished blood supply in the endplates, and anulus fibrosus (AF) tears [2-4].  Current 
therapies for treating disc degeneration include conservative non-surgical approaches 
and surgical intervention such as discectomy, spinal fusion, and total disc replacement; 
however, these therapies do not restore the structure and function of the native IVD.   
Disc degeneration is believed to originate in the nucleus pulposus (NP) region of 
the disc [4]; therefore, there is significant interest in tissue engineering strategies to 
regenerate the NP.  The native NP is composed primarily of water, proteoglycans and 
collagen type II.   Degeneration of the NP is characterized by decreased water content, 
decreased cellularity, loss of proteoglycans in the extracellular matrix (ECM), and 
increased matrix stiffness [5, 6].  Aging itself is associated with an early loss of the juvenile 
NP cell population that is originally derived from the embryonic notochord [7-9], and 
disappears from the human disc within the first decade of life.  These large, highly 
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vacuolated [9, 10] notochordal-like NP cells organize in cell clusters [9, 11], and have been 
shown to produce a proteoglycan-rich matrix [12], and are therefore thought to be 
involved in generating and maintaining the highly hydrated NP tissue.  Furthermore, 
these cells have been shown to secrete soluble mediators that regulate proteoglycan 
synthesis by other cell types [13-16].  Therefore, the aging associated loss of this 
notochordal-like NP cell population has been hypothesized to be a contributing factor to 
IVD degeneration [17], and suggests that promoting or maintaining a notochordal-like NP 
cell phenotype may be useful for NP tissue regeneration.   
Cell-based strategies for IVD regeneration rely on three main components: an 
appropriate cell source, a biomaterial or scaffold, and differentiation conditions suitable 
for generating an NP-like matrix [18].  Strategies for NP regeneration have utilized one or 
more of these components, including cells cultured within scaffolds in vitro and in vivo 
[19-21], and cells delivered either alone or within an injectable biomaterial carrier [22].  
Cell delivery alone would limit damage to the adjacent AF tissue [23], however, 
calcification of the cartilaginous end plates severely limits diffusion of glucose and oxygen 
into the disc that is believed to create a hostile extracellular environment not well suited 
to maintain cell viability or matrix synthesis [3, 24, 25].  Therefore, it is likely that 
functional regeneration of NP tissue will require an appropriate scaffold and biological 
signals that promote cell survival and maintain or promote an NP cell phenotype and 
matrix production.  A variety of synthetic, natural, and composite materials have been 
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investigated for NP regeneration (see Section 1.4), mainly in the form of hydrogels due to 
the highly hydrated nature of the native NP.  Unlike biomaterials for other tissue 
engineering applications [26, 27], few peptide and protein functionalized scaffolds to 
direct biological responses of NP cells have been developed [28].  Furthermore, scaffold 
biochemical and physical properties that promote or maintain an immature NP cell 
phenotype are currently unknown.   
The ECM environment, including ECM ligand and mechanical stiffness, are 
known to be key regulators of cell behaviors such as adhesion, survival, phenotype and 
organization.  Previous work in our laboratory suggests immature NP cells reside in an 
environment rich in laminin ECM proteins and that these cells highly express numerous 
laminin receptors as compared to cells of the adjacent AF [29-32]. Additionally, soft (< 0.7 
kPa), laminin-containing basement membrane extract substrates have been shown to 
promote immature NP cell rounded morphology, cell-cell interactions, and proteoglycan 
production [33].  These findings suggest that NP cell phenotype is dependent upon both 
ECM ligand and mechanical properties. 
The central hypothesis of this research was that a laminin presenting hydrogel 
scaffold with matrix elasticity similar to that of the native NP would support cell adhesion, 
survival and maintenance of phenotype.  In the studies presented here, a poly(ethylene 
glycol)-laminin (PEG-LM111) conjugate with functional acrylate groups for crosslinking 
was synthesized and characterized (Chapter 2), to allow for protein coupling to both 
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photocrosslinkable and injectable PEG-based biomaterial scaffolds.   PEG hydrogels were 
chosen since they readily allow for incorporation of biological signals derived from the 
native ECM [26, 34], and, due to their non-fouling properties, PEG hydrogels provide a 
suitable environment for studying cell-ligand interactions.  Studies were conducted to 
evaluate the effects of photocrosslinkable hydrogel formulation, including hydrogel 
stiffness and laminin ligand concentration, on immature NP cell phenotype in vitro 
(Chapter 3).   Additionally, studies were performed to examine the role of an injectable 
laminin functionalized hydrogel carrier in promoting cell survival and cell retention in 
the IVD space (Chapter 4).   
 
1.1 Intervertebral Disc Structure and Function 
The IVD is a fibrocartilaginous tissue that provides load support, flexibility and 
energy dissipation in the spine.  The IVDs are situated between each of the cervical, 
thoracic and lumbar vertebral bodies of the spinal column.   Each disc is comprised of 
three primary anatomical regions: the outer AF, the centrally located inner NP (Figure 1), 
and the cartilaginous endplates that are situated on top and bottom of each disc, adjacent 
to the vertebral bodies [35].  The hyaline cartilage endplates separate the disc from the 
vertebral bodies, and provide a pathway for nutrient transfer from the vascularized 
vertebral bodies to the avascular disc [36].   
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The AF is composed of highly organized collagen fibers (approximately 70% dry 
weight) arranged in concentric rings, or lamellae, that enclose the NP (Figure 1) [37].  
Within the AF lamellae, the collagen fibers lie parallel to each other at approximately a 
60°-70° angle to the axis of the spine, with each successive layer altering in fiber direction 
(approximately 120° to each other) [38].  The periphery of the AF attaches to the posterior 
longitudinal ligament and inserts into the vertebral body.  Mechanically, the AF acts to 
resist compressive and torsional stresses, and aids in stabilizing the spine by restricting 
motion between adjacent vertebrae.  The ECM of the AF has a low proteoglycan content 
compared to the NP, and is mainly composed of type I collagen, with smaller amounts of 
types III, V, VI, IX, and XI [39].   The outer AF consists primarily of type I collagen fibers, 
with increasing percentage of type II collagen towards the innermost region [40], which 
merges horizontally with the NP.  The cells of the AF also vary from the outer to inner 
regions.  The outer AF contains elongated fibroblast-like cells that align parallel to the 
collagen fibers within each concentric ring, and the inner AF, which integrates with the 
NP, contains more chondrocyte like cells [41].  Overall, the cell density of the AF is very 
low compared to other tissues, containing approximately 9 x 106 cells/cm3 [42].   
The NP is a gelatinous, highly hydrated tissue that resists compressive spinal loads 
and distributes them radially to the AF.  With aging and degeneration, a number of 
biological and anatomical changes occur in the human NP (see Section 1.2).  The young, 
healthy human NP is comprised primarily of water (70 – 90% of wet weight), 
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proteoglycans (65% of dry weight) and a random network of collagen fibrils dispersed 
throughout a proteoglycan rich ECM [40, 43].  Proteoglycans in the NP ECM contain 
mainly chondroitin sulphate and keratan sulphate side chains [44, 45], which play an 
important role in imbibing water.  The high proteoglycan content of the NP ECM results 
in a negative fixed-charged density and a high interstitial swelling pressure.  Smaller 
proteoglycans such as biglycan, decorin, lumican and fibromodulin are also present [46, 
47].  The collagen content of the NP is mainly composed of type II collagen (15 – 20% of 
dry weight), and small quantities of types III, VI, IX, and XI [39].  NP cell density is very 
low (4 x 106 cells/cm3) as compared to other avascular tissues such as cartilage [42].  
Additionally, the NP cell population varies considerably with age.  In humans, the NP is 
initially populated by large, vacuolated cells derived from the embryonic notochord.  
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These morphologically distinct NP cells disappear within the first decade of life, and are 
replaced by a lesser number of smaller, chondrocyte-like cells [9].    
 
 
Figure 1. Matrix structure and cellular organization in the immature IVD. 
Cytoskeletal staining for AF (actin) and NP (vimentin) cells in immature porcine IVD 
tissues.  Adapted from [48].  
 
1.2 Intervertebral Disc Degeneration and Aging  
Disc degeneration is complex and is still not clearly defined; however, it is thought 
to be a process of premature aging, since changes associated with degeneration mimic 
those of aging, but occur at a faster rate [49].  IVD degeneration is linked to numerous 
mechanical, biochemical, nutritional, and genetic factors, which can lead to an imbalance 
between catabolism and anabolism [50].  Non-physiological mechanical loads may initiate 
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or contribute to degeneration [51, 52].  Additionally, mutations in ECM proteins such as 
collagen types I, IX and XI, and aggrecan have been shown to correlate with IVD 
degeneration [53-57].   Calcification of the cartilaginous endplates limits diffusion of 
nutrients such as glucose and oxygen into the disc [3, 24, 58], creating an acidic and 
hypoxic environment that may not be well suited for maintaining high cell viability and 
matrix synthesis [2, 4, 59].  In addition to endplate changes, other anatomical features of 
disc degeneration include loss of disc height and hydration, extrusion and tears, and disc 
herniation [3, 4, 60].  These changes may lead to altered mechanical loading, nerve 
compression, spinal canal impingement and inflammation, which contribute to 
symptomatic back pain [61].   
Disc disorders and related pain may be secondary to changes that first occur in the 
NP region of the IVD (Figure 2), including significant alterations in tissue cellularity, 
matrix composition, and structure [2-4].  Cell density decreases shortly after birth, with 
increasing levels of cell death in the NP with aging-related degeneration [4, 62, 63].  The 
biochemical composition of the NP ECM changes significantly with degeneration, and is 
characterized by decreased concentration of proteoglycans [2], an increase in the amount 
of denatured type II collagen [2, 64], and increased fibronectin content [65].  Formation of 
fibronectin fragments may contribute to further degeneration by downregulating 
aggrecan synthesis and upregulating production of matrix metalloproteinases (MMPs) 
[6]. Loss of proteoglycans, particularly the degradation of large aggrecan molecules [66, 
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67], and decreased water content leads to a decrease in the osmotic pressure, which 
impairs the mechanical functionality of the NP.  This may result in higher compression 
loads being transferred to the AF, contributing to tears, cleft formation or rupture.   
 
 
Figure 2. Representative images of changes in tissue hydration and 
composition that occur with aging and degeneration.  Images courtesy of L.A. Setton. 
 
1.3 Nucleus Pulposus Cells and Disc Degeneration  
1.3.1 Notochordal Nucleus Pulposus Cell Fate  
The IVD contains cells of both notochordal and mesenchymal origins that 
populate the NP and AF regions of the disc, respectively.   During embryonic 
development, the notochord, a rod-like line of cells that guides development of the neural 
tube and the vertebral column, is surrounded and condensed by mesenchymal cells, 
which form the vertebrae and AF [68, 69].  The entrapped notochordal cells then take part 
in formation of the NP [7, 38, 69, 70].  These ‘notochordal-like’ NP cells synthesize a 
proteoglycan-rich matrix [12], and have been shown to secrete soluble mediators that 
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regulate proteoglycan synthesis by other cell types [13-16, 71].  These are large, highly 
vacuolated cells containing large glycogen deposits, and poorly developed mitochondria 
surrounded by rough endoplasmic reticulum [9, 63, 72, 73].  Notochordal-like cells 
organize in cell clusters with strong cell-cell interactions [9, 11, 73], and express cadherins 
(Figure 3) [73, 74].  Additionally, notochordal-like NP cells highly express cytoskeletal 
proteins including cytokeratins (isoforms 8, 18, 19) (Figure 3) and vimentin intermediate 
filaments [74-76].   
In humans, notochordal-like cells disappear within the first decade of life, and are 
replaced by smaller, more ‘chondrocyte-like’ cells [38, 77].  The disappearance of this cell 
population coincides with changes in NP matrix biochemistry and mechanical properties 
that are characteristic of disc degeneration, including decreased cellularity, proteoglycan 
levels, and water content, as well as reduced swelling pressure, and increased matrix 
stiffness [3, 5, 6, 60, 78, 79].  Additionally, studies have shown that susceptibility to disc 
degeneration in certain breeds of dogs is linked to a decline in NP notochordal-like NP 
cell content [11, 13, 69, 80].  Therefore, notochordal-like cell disappearance may be an 
initiating or contributing factor to degenerative disc disease [17, 81].  In certain animals, 
such as pigs, rats, and non-chondrodystrophoid dogs, notochordal-like NP cells are 
retained well past the age of skeletal maturity [82], which allows for controlled ex vivo 
study of their cell biology and function.   
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Figure 3. Expression of cytokeratin 8 (left) and N-cadherin (right) in immature 
rat and porcine NP tissues.  Scale bar = 50 µm.  Images of rat tissue immunostaining 
from [83].   
 
1.3.2 Defining the Nucleus Pulposus Cell Phenotype 
As discussed above, altered NP cellularity is a noteworthy feature of disc 
degeneration.  Therefore, significant interest exists in defining the NP cell phenotype, 
particularly that of notochordal-like NP cells, to better inform the development of cell-
based strategies for NP regeneration.  Recently, numerous studies have sought to define 
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the NP cell phenotype by evaluating biomarker expression in immature or non-
degenerate NP cells as compared to that in AF cells (Table 1) or articular chondrocytes.  
Notochordal-like NP cells and mature, or ‘chondrocyte-like’, NP cells have been shown 
to exhibit some similarities in gene expression profiles.  Both cell types express similar 
levels of aggrecan, collagen II and Sox9, which are typical markers of a chondrogenic 
phenotype [84].  Notochordal-like NP cells more highly express cell-associated laminin 
ECM proteins and laminin receptors as compared to AF cells (Section 1.5).  Other distinct 
expression patterns in NP cells, including higher expression of cytokeratins 8, 18 and 19, 
and N-cadherin (cadherin-2), have been shown to be expressed at higher levels in 
notochordal-like NP cells as compared to mature NP cells [85].  Overall, these studies 
provide useful biomarkers for understanding the transition between notochordal-like and 
chondrocyte-like NP cells, and for optimizing NP cell phenotype for cellular and tissue 
engineering therapies for treating IVD degeneration.   
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Table 1. Expression of proposed NP cell phenotypic markers.  FC = flow 
cytometry; IHC = immunohistochemistry.  
Marker Species Elevated in NP ( vs. AF) Reference 
Cell surface receptor  
Integrin α6 (CD49e) Rat, Porcine, Human Protein (FC, IHC) [30, 84] 
Integrin α3 (CD49c) Rat, Porcine, Human Protein (IHC, FC) [30] 
Integrin β4 (CD104) Rat, Porcine, Human Protein (IHC) [30] 
Lu (BCAM, CD239)) Rat, Porcine, Human mRNA, Protein (FC,IHC) [30] 
CD24 Rat, Human mRNA, Protein (FC, IHC) [86-88] 
 Bovine mRNA [85] 
CD151 Rat, Porcine, human mRNA, Protein (FC,IHC) [30] 
CDH1 (CD324) Human, Rat Protein (IHC) [73, 74] 
CDH2 (CD325) Human, Bovine, Rat mRNA, Protein (IHC) [73, 85] 
Galectin-1 Rat, Porcine, Human mRNA, Protein (IHC) [88] 
Syndecan 4 Rat mRNA, Protein (Western) [88, 89] 
Cytoskeleton 
KRT8 Bovine 
mRNA,Protein (IHC) 
higher for cells in clusters 
[85, 90] 
 Porcine Protein (IHC)  [90] 
 Human Protein (IHC) [74, 75, 91] 
KRT18 Bovine 
mRNA, Protein (IHC) 
higher for cells in clusters 
[85, 90] 
 Human mRNA, Protein (IHC) [74, 75, 91] 
 Canine mRNA, Protein (IHC) [92] 
KRT19 Rat, Bovine mRNA [85, 87] 
 Human mRNA, Protein (IHC) [74, 75, 91, 93] 
Vimentin Human, Rat, Bovine Protein (IHC, Western) [74, 75, 91, 94] 
 Rat, Porcine mRNA  
Matrix-related protein 
Laminin α5 Rat, Porcine, Human Protein (IHC) [30] 
Laminin γ2 Porcine Protein (IHC) [95] 
Type II collagen  Porcine mRNA [84] 
 Porcine Protein (BC, IHC) [40, 96] 
Aggrecan Porcine, Bovine mRNA [84, 85] 
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1.4 Cell Based Therapies for Treatment of Disc Degeneration 
Significant interest exists in cell based therapies for treating IVD disorders, with 
the majority of strategies focused on regenerating or repairing the NP region of the disc 
as a means to impede or reverse disc degeneration.   These include cells cultured with 
biomaterial scaffolds in vitro, delivery of cells alone, and cells delivered to the NP region 
of the disc within an injectable biomaterial carrier.   
1.4.1 NP Cell-Biomaterial Constructs   
Due to the avascular nature of the IVD, and the limited nutrient supply to the NP 
region of the disc, a suitable scaffold will likely be necessary for NP tissue regeneration in 
vivo.  Both natural and composite biomaterials have been investigated for NP 
regeneration (Table 2), mainly in the form of hydrogels due to the fact that they 
approximate the gel-like properties of the native NP tissue.  Few studies have examined 
synthetic hydrogels as potential tissue engineered scaffolds for NP regeneration; 
however, synthetic-natural hybrid materials are being actively investigated.  A wide 
variety of scaffolds have shown some ability to maintain or promote a rounded NP-like 
cell phenotype, and to promote collagen and proteoglycan matrix generation by the 
entrapped cells; however, there is little agreement on the ECM composition required to 
achieve a functional tissue engineered NP construct.      
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Table 2. Representative biomaterials evaluated for NP ECM regeneration.  
 
  
 Naturally derived materials such as hyaluronan, collagen, alginate, chitosan, 
carboxymethylcellulose and agarose have all been studied as potential scaffolds for NP 
Scaffold Material Cell Source(s) Reference 
Alginate 
Ovine NP 
HNPSV-1 
Bovine NP 
Human AF, NP 
Porcine AF, NP 
Rabbit AF, NP 
[97-100] 
[101] 
[102] 
[103] 
[104] 
[105] 
Agarose Human AF, NP [103] 
Collagen 
Human AF, NP 
Ovine NP 
[103] 
[106] 
Fibrin Gel Human AF, NP [103, 107] 
Atelocollagen 
Bovine NP 
HNPSV-1 
Rabbit MSCs 
[108] 
[101] 
[109] 
Carboxymethylcellulose Bovine NP [110] 
Hyaluronan 
Rat MSCs 
Human MSCs 
[111] 
[112] 
Hyaluronan/elastin-like polypeptide  Human IVD [113] 
Hyaluronan-poly(N-isopropylacrylamide)  Human MSCs [114, 115] 
Chitosan 
Bovine NP, AF 
Human MSCs 
[116] 
[117, 118] 
Collagen type II/Polyethylene 
glycol/Hyaluronan 
Human ADSCs [119] 
Collagen/hyaluronan Bovine AF, NP [120] 
Fibrin/hyaluronan Porcine NP [121] 
Calcium Polyphosphate Bovine NP [122] 
Polyethylene glycol Human MSCs [123] 
Gelatin/Chondroitin-6 Sulfate/Hyaluronan Human NP [124] 
Small Intestinal Submucosa Human AF, NP [125] 
Decellularized Porcine NP Tissue  Human ADSCs [126, 127] 
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tissue engineering since they are components of or have macromolecular properties 
similar to the natural ECM [128]. The use of chitosan was investigated in a study by 
Roughley and coworkers, in which chitosan was crosslinked by glycerophosphate in the 
presence of hydroxyethyl cellulose [116].  Results showed that bovine NP cells were able 
to proliferate and retain almost 75% of sGAG produced by the cells over 20 days in culture; 
however sGAG levels achieved were only approximately 10% of that found in the native 
bovine NP, and proteoglycan production eventually diminished.  One limitation of using 
naturally derived materials is that their physical properties can not be easily controlled.  
Therefore, researchers have modified natural polymers to contain functional groups that 
allow for photopolymerization.  Since alginate has been shown to maintain a rounded NP-
like cell morphology in culture, Chou and coworkers attempted to overcome its lack of 
mechanical integrity by modifying alginate to contain methacrylate groups for 
photocrosslinking [102].  Although increasing the degree of methacrylation did lead to 
increased gel modulus, cell viability decreased. Reza and coworkers utilized similar 
chemical methods to develop hydrogels with tunable mechanical properties by 
methacrylating carboxymethylcellulose, and showed that specific formulations promoted 
a rounded cell phenotype and pericellular proteoglycan deposition [110], suggesting 
maintenance of NP cell phenotype. 
As an alternative to naturally derived biopolymers, tissue-based scaffolds have 
also been generated for a variety of tissue engineering applications by decellularizing 
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xenogenic or allogenic tissues. Le Visage and coworkers utilized porcine small intestine 
submucosa, which is primarily made up of collagen type I, GAGs and growth factors, as 
a bioactive scaffold for culturing human disc cells obtained from degenerated discs [125].  
Results showed that over 3 months in standard cell culture conditions, the cells were able 
to migrate into the scaffold, where they remained and synthesized sGAG.  Tissue-based 
scaffolds formed from the host-tissues themselves may be advantageous in directing cells 
to generate appropriate matrix molecules, since the scaffolds already contain the 
appropriate ECM composition, architecture and biological signals. Recently, a biomimetic 
acellular porcine NP hydrogel was developed [127] and reported to promote proteoglycan 
and collagen deposition, and ECM remodeling [126].    
1.4.2 Injectable Biomaterials for Cell Delivery  
Although NP tissue engineered scaffolds grown in vitro before being implanted 
into the disc space are advantageous in that cells would be able to generate appropriate 
ECM in a controlled, favorable environment, implanting the scaffold would cause 
significant damage to the AF. Cell delivery to the disc space via injection would limit 
damage to the adjacent AF tissue; however, calcification of the cartilaginous end plates 
severely limits diffusion of glucose and oxygen into the disc, creating a hostile 
extracellular environment not well suited to maintain cell viability or promote matrix 
synthesis.  Additionally, a recent study of mesenchymal stem cells (MSCs) delivered to 
rabbit IVDs raised concern that delivered cells can migrate out of the nucleus and induce 
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undesirable osteophyte formation [129].  Therefore, it is likely that functional regeneration 
of NP tissue via cells delivered to the disc space will require an appropriate biomaterial 
carrier to retain cells in the IVD space and to promote NP cell survival and phenotype. 
Cell delivery to the IVD has been performed in animal models for IVD 
regeneration both with and without the use of a biomaterial carrier, and shown that 
reinsertion of autologous disc cells or stem cells delays degeneration in experimental 
models of degeneration [111, 130-134].  Ganey and colleagues studied a canine model, in 
which autologous disc cells were delivered without any carrier matrix to injured discs, 
and showed significantly better maintenance of disc height and structure in dogs 
receiving transplants as compared to controls [130].  Meisel and colleagues have brought 
autologous disc cell transplantation to clinical study, comparing safety and efficacy of cell 
transplantation plus discectomy with discectomy alone [135].  Although these studies 
have shown some maintenance of disc height and reduction in patient pain compared to 
discectomy alone, it is thought that a biomaterial carrier will improve cell retention and 
survival in the disc space, and may lead to the generation of new matrix. A study by 
Bertram and colleagues provided strong evidence for this, in which luciferase expressing 
cells were injected into a nucleotomized rabbit disc space either in media or within a two 
component fibrin matrix that polymerizes upon injection in to the disc space [136].  Results 
showed that approximately 30-50% of the cells injected within the fibrin biomaterial 
remained 30 minutes after injection, whereas media injected cells were rapidly lost from 
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the disc space. While the fibrin carrier improved efficiency of cell delivery to the disc 
space, it may not be the ideal biomaterial for generating an NP-like matrix.  Crevensten 
and colleagues isolated bone marrow derived MSCs, stained the cells with a CM-DiI 
membrane stain and delivered them into rat coccygeal discs with a hyaluronan carrier 
[111].  Results showed the injected cells survived and proliferated, and could be detected 
within the disc space over the 28-day period; however, there was a marked decrease in 
cell number over the first 7 days in culture. In a more recent study by Sakai and colleagues 
[109], autologous MSCs were transplanted from bone marrow into a rabbit model of disc 
degeneration within an atelocollagen carrier.  Results showed that 24 weeks post MSC-
transplantation, degenerated discs that received MSCs regained a disc height of 
approximately 91%, as compared to about 67% for the sham operated group. 
Additionally, X-gal staining for LacZ expressing transplanted MSCs showed increased 
staining at 24 weeks as compared to 2 weeks, suggesting that injected cells survived and 
proliferation within the disc space.  Since this study did not include a control group of 
cells without biomaterial, it is not clear exactly what therapeutic role was played by the 
atelocollagen carrier; however, these results combined with previous findings [101] 
suggests that an atelocollagen carrier may help promote an NP-like phenotype.   
For detecting cells within the region of interest at various time points, much of the 
work using animal models of disc degeneration has relied on histological techniques 
subsequent to animal sacrifice at specific time-points, which precludes in vivo assessment 
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and longitudinal tracking of cell therapy. To address this, Saldanha and colleagues labeled 
MSCs with iron oxide particles, delivered the cells within a fibrin gel to the rat IVD, and 
demonstrated initial detection of the transplanted cell population via magnetic resonance 
imaging (MRI) [123].  Although in vivo longitudinal cell tracking was not performed, this 
study introduced a new technique that may be useful for evaluating biomaterial carriers’ 
ability to promote cell survival and retention at the injection site. More recently, luciferase 
expressing porcine MSCs were delivered within a fibrin matrix to the disc space of 
minipigs following partial nucleotomy to assess the persistence and activity of delivered 
cells [137].  Results demonstrated that only 7% of the injected cells could be detected 3 
days post injection, suggesting a need for improved biomaterial carriers and increasing 
focus on anulus reconstruction to reduce cell loss following delivery. 
Towards developing improved injectable carriers, a number of groups have 
modified natural materials and created hybrid natural-synthetic materials to obtain 
greater control over material properties. Halloran and coworkers compared 
uncrosslinked atelocollagen to enzymatically crosslinked, atelocollagen type II based 
scaffolds containing varying concentrations of aggrecan and hyaluronan [108].  Bovine 
NP cells were cultured within the scaffolds in vitro for 7 days, with results showing that 
crosslinking did not reduce cell viability and improved proteoglycan retention within the 
scaffolds when compared to uncrosslinked atelocollagen.  The authors did not assess the 
effects of crosslinking on gelation time, which is an important parameter to control in 
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order to prevent cells from leaking back out through the injection site following delivery.  
An injectable biomaterial for NP regeneration was recently developed in which type II 
collagen was crosslinked with a 4-arm PEG derivative, enriched with hyaluronan and 
used to entrap adipose derived stem cells (ADSCs) [119].  Gelation occurred in less than 
10 minutes under physiological conditions, and NP cell viability remained high (>80%) 
over 14 days in culture.  In another recent study, Peroglio and colleagues developed 
injectable, thermoreversible hyaluronan-based hydrogels for NP cell encapsulation and 
showed that the materials gelled upon heating to approximately 30°C [114].  Short term 
in vitro studies demonstrated that scaffolds could induce human MSC differentiation 
towards the disc phenotype [115].  Although these studies represent steps towards the 
development of novel injectable biomaterials for cell delivery, additional in vitro studies 
are needed to further investigate cell phenotype and matrix production within these 
biomaterials, as well as in vivo studies to assess their ability to promote NP cell retention 
and survival in the disc space.   
 
1.5 Laminins and the Intervertebral Disc 
It is well-known that ECM proteins play an important role in regulating cellular 
functions.  Laminins are cross-shaped heterotrimeric ECM proteins consisting of α, β, and 
γ polypeptide chains (Figure 4)  that form at least 15 different known laminin isoforms, 
with expression profiles varying significantly between tissue types and developmental 
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stages [138]. Laminins mediate matrix assembly and a number of cellular functions 
including adhesion, survival, migration and differentiation [138, 139].  Cellular 
interactions with laminins are mediated via integrin receptors including α3β1, α6β1, 
α7β1, α6β4 and α1β1, and non-integrin-type receptors, such as Lutheran (CD239), 
syndecans, α-dystroglycan and tetraspanin (CD151) [138, 140-142].   
  
Figure 4. Structure and ligand binding regions of laminin-111 and -511 isoforms. 
Image adapted from [138].  Laminin receptor binding and cleavage information from 
[138, 140, 143]. 
Cell attachment to laminins directs many cellular processes.  Numerous groups 
have demonstrated that laminins and their receptors, particularly integrins α6β1 and 
α6β4, contribute to the invasive phenotype and survival of carcinoma cells [144-148].  
Laminin-511 (LM511) has been shown to promote endothelial cell adhesion and migration 
 23 
[149], and reported effects of laminin-111 (LM111) include cell proliferation, and 
induction or maintenance of the differentiated state [139].  Laminins also induce stem cell 
differentiation into different cell lineages.  LM111 induces neurite outgrowth in human 
MSCs [150], and has been shown to regulate neural differentiation of human embryonic 
stem cells [151].  Finally, Battista and coworkers demonstrated that LM111 increased the 
ability of embryonic stem cells to differentiate into cardiomyocytes [152].  These findings 
suggest that laminins play an important role in regulating and directing cell phenotype, 
and may be able to direct stem cell differentiation.   
Previous studies have demonstrated NP cell – laminin interactions unique to the 
immature NP region of the disc, suggesting that laminins may be important contributors 
to region-specific IVD biology [30-32, 46].  Immunohistochemistry results demonstrated 
higher expression levels of the laminin α5 and γ1 chains in immature porcine and rat NP 
tissues (Figure 5), as well as in juvenile human NP tissues, as compared to AF tissues [30, 
95].  Furthermore, a number of laminin receptors (integrin α3, α6, β4 subunits, as well as 
non-integrin receptors Lutheran (CD239) and tetraspanin (CD151)) have been shown to 
be uniquely expressed in immature NP tissues [30-32].  Strong expression of integrins α6 
and β4, and CD239 was observed for immature porcine and rat NP tissues.  Expression 
patterns varied slightly for immature (12-year-old) human IVD tissues, which more 
highly expressed integrins α3 and β1 [30].  Together these findings indicate that both 
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laminins and receptors which mediate cellular interactions with laminins are distinctly 
expressed in the NP region of the immature IVD.  
 
Figure 5. Expression of laminin α5 (LM511) and γ1 chains (LM511 or LM111) 
and LM332 in immature rat IVD tissue (1 month old).  Green = laminin; Red = cell 
nuclei.  Scale bars = 50 µm.  Image adapted from [83].        
 
Immature NP cell adhesion to LM111 was found to be mediated by the α6 integrin 
subunit, particularly for larger, notochordal-like cells [31].  This finding differs from a 
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study of human IVD cell interactions with ECM proteins, which identified integrin 
subunits α3, α5 and α1 as key mediators of human NP cell adhesion to LM111 [29]. 
Additional studies have shown that porcine NP cells adhere in higher numbers to 
laminins (LM111, LM511, and LM332) as compared to cells from the adjacent AF (Figure 
6).  Furthermore, NP cells spread more on and attached with greater strength of adhesion 
to laminins, particularly LM332 and LM511 isoforms, as compared to collagen II or 
fibronectin [95].  Overall, these findings demonstrate that laminin and laminin receptor 
expression identified in immature NP tissues translates to functional NP cell adhesion 
behaviors.         
  
 
Figure 6. Primary porcine NP and AF cell adhesion to LM111, LM332 and LM511 
isoforms.  NP cells were found to attach to laminin substrates at significantly higher 
numbers as compared to AF cells (p<0.01.  Image from [95].   
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In addition to evaluating notochordal-like NP cell adhesion to ECM ligands, 
previous studies in our laboratory have investigated the role of substrate stiffness in 
regulating NP cell behaviors.  It is well known that substrate elasticity plays an important 
role in modulating cell adhesion, spreading, motility, and phenotype [153-155].  For 
primary notochordal-like NP cells cultured on substrates of varying stiffnesses and ligand 
presentation in vitro, soft, laminin-rich basement membrane extract (BME) substrates 
were found to promote cell-cell interactions and formation of multi-cell clusters similar to 
those observed in situ (Figure 7) [33].  Furthermore, NP cells cultured on soft BME 
substrates produced significantly more sGAG as compared to cells cultured on rigid BME 
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or collagen II presenting substrates.  Together these findings demonstrate that NP cell 
organization and phenotype is dependent upon both substrate stiffness and ECM ligand.   
 
 
 
Figure 7. NP cell organization and morphology on soft (100 Pa, top row) or stiff 
(15200 Pa, bottom row) polyacrylamide gels functionalized with either laminin-rich 
BME or Collagen II.  Green = actin.  Red = cell nuclei.  Image adapted from [33].   
 
1.6 Protein Functionalized Poly(ethylene glycol) Scaffolds 
PEG has been widely used in drug delivery [156, 157] and tissue engineering 
applications [26, 128, 158] since it is biologically inert and can be coupled directly to 
bioactive peptides and proteins.  Due to its non-fouling and tunable mechanical 
properties, PEG provides a suitable environment for studying ECM ligand and matrix 
stiffness effects on cell behavior.  Therefore, full length ECM proteins such as collagen 
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[159, 160], fibrinogen [159, 161], and laminin [162], and numerous growth factors [163-166] 
have been incorporated into PEG hydrogels for controlled study of the effect of 
biochemical and mechanical cues on cell behavior.    
Seliktar and coworkers developed photocrosslinkable PEG-fibrinogen hydrogels 
via a two-step synthesis process in which fibrinogen was denatured to expose free thiols 
for conjugating the protein to PEG-diacrylate (PEG-DA) [161]. PEGylated fibrinogen was 
then crosslinked upon the addition of PEG-DA and exposure to UV light to form 
proteolytically degradable hydrogels with elastic moduli dependent on the molecular 
weight of the PEG constituent and the total weight percent polymer. PEG-fibrinogen 
scaffold composition was shown to affect smooth muscle cell morphology and migration.  
Additionally, PEG-fibrinogen scaffold physical properties were found to influence 
contraction of cardiomyocytes [167] and smooth muscle cell spreading and remodeling 
[168].  PEG-collagen I and PEG-albumin hydrogels were synthesized in a similar manner, 
and were shown to sustain both cell adhesion and proteolytic degradation [159].   Overall, 
these findings demonstrate the use of Michael-type addition reactions between various 
proteins and PEG to form biosynthetic materials that emulate the biochemical 
characteristics of the native ECM with added control over scaffold physical properties.    
Since free thiol groups are rarely present in native non-denatured proteins, 
bioactive hydrogels are most commonly synthesized by PEG-N-hydroxysuccinimide ester 
coupling to free amino groups of lysine residues within ECM proteins or peptides [34].  In 
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this manner, Willits and coworkers synthesized PEG-collagen I and PEG-laminin 
conjugates, and crosslinked conjugates upon addition of PEG-DA and exposure to UV 
light [160, 162].   Laminin conjugation to PEG hydrogels resulted in improved dorsal root 
ganglia neurite extension in hydrogels of varying stiffnesses [162].  Together, these 
findings illustrate the use of protein functionalized PEG hydrogels for controlled in vitro 
study of ECM ligand presentation and matrix stiffness on cell behaviors.     
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2. Photocrosslinked PEG-LM111 Hydrogel Synthesis and 
Characterization 
2.1 Introduction 
It is widely known that ECM protein composition and matrix elasticity play 
important roles in regulating cellular function.  Previous studies in our laboratory have 
demonstrated NP cell – laminin interactions that are unique to the immature disc, 
suggesting that laminins may be important contributors to NP-specific cell biology.  
Immunohistochemistry and flow cytometry results demonstrated higher expression 
levels of the laminin α5 and γ1 chains, laminin receptors (integrin α3, α6, β4 subunits, 
CD239), and related binding proteins in NP cells as compared to cells from the adjacent 
AF [30-32].  Additional studies have shown that soft, laminin–rich BME substrates 
promote immature NP cell morphology, cell-cell interactions, and proteoglycan synthesis 
for cells of the NP [33].   Finally, immature porcine NP cells adhere to laminins in higher 
numbers as compared to cells from the adjacent AF [95].  These findings provide support 
for known interactions between immature NP cells and multiple laminin isoforms that 
regulate NP cell biology, and motivate our interested in developing a LM111 
functionalized hydrogel with tunable mechanical properties. 
PEG hydrogels have been widely used in tissue engineering applications since 
they are biocompatible, hydrophilic polymers that readily allow for incorporation of 
biological signals derived from the native ECM [128].    The non-fouling nature of PEG, 
combined with its tunable mechanical properties, allows for control over biological signal 
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presentation and hydrogel stiffness.  Therefore, full length ECM-derived proteins, 
including collagen, fibrinogen and laminin, have been covalently coupled to PEG 
hydrogels for a variety of tissue engineering applications and shown to influence cell 
behavior in both 2D and 3D [34, 162, 168, 169].    
The objective of this work was to develop a LM111-functionalized PEG hydrogel 
suitable for evaluating the effects of hydrogel stiffness and LM111 concentration on NP 
cell phenotype in vitro.  We describe here the synthesis and characterization of multiple 
PEGylated LM111 (PEG-LM111) conjugates with functional acrylates for crosslinking, and 
subsequent hydrogel formation upon the addition of PEG-DA and exposure to UV light.  
The effect of degree of LM111 modification on PEG-LM111 conjugate bioactivity and 
protein incorporation into PEG-LM111 hydrogels was evaluated.  Based on these findings, 
a single PEG-LM111 conjugate was chosen and evaluated for its ability to promote NP cell 
survival within 3D photocrosslinked PEG-based hydrogels.   
 
2.2. Materials and Methods 
2.2.1 PEG-Laminin (PEG-LM111) Conjugate Synthesis  
 Laminin-111 (LM111, Trevigen®, Gaithersburg, MD) was PEGylated with 
acrylate-PEG-N-hydroxysuccinimide (Ac-PEG-NHS, MW = 10kDa, Creative PEGworks, 
Winston Salem, NC) to introduce functional acrylate groups for crosslinking.  LM111 was 
dialyzed into a 0.1M sodium bicarbonate buffer, pH 8.5, and diluted to a concentration of 
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2 mg/ml.  Ac-PEG-NHS was solubilized in ice cold 0.1M sodium bicarbonate buffer and 
added to LM111 solution at 10:1, 25:1, 100:1 or 500:1 molar ratio of Ac-PEG-NHS to LM111.  
Reactions were carried out for two hours at room temperature.  Precursor PEG-LM111 
conjugate solutions were dialyzed against 1x PBS to remove any unreacted Ac-PEG-NHS.  
LM111 concentration in each PEG-LM111 conjugate precursor solution was determined 
by measuring the absorbance at 280 nm, and conjugates were stored at -80°C until further 
use.   
2.2.2 Degree of LM111 Modification 
 A TNBS (2,4,6-trinitrobenzene sulfonic acid) assay [170] was modified to measure 
the free amino groups in each PEG-LM111 conjugate compared to unmodified protein, 
and to estimate the degree of modification due to Ac-PEG-NHS substitution.  Each PEG-
LM111 conjugate and unmodified LM111 were diluted to 500 µg/ml in PBS, which was 
determined to be within the linear range for LM111 using this assay.   TNBS was diluted 
to 0.01% in 0.1M sodium bicarbonate buffer, pH 8.5.  Samples (PEG-LM111 conjugates or 
LM111) were mixed with 0.01% TNBS at a 1:1 ratio by volume, and incubated for 30 
minutes at 60°C.  Absorbance was measured at 340 nm using a microplate reader (Enspire, 
PerkinElmer, Waltham, MA) and used to calculate degree of modification (%): 100 x {1 – 
((A340 PEG-LM111)/(A340 LM111))}.  An ANOVA was performed to analyze degree of 
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modification, using Tukey’s post hoc test (p<0.01, n=3) to detect differences between PEG-
LM111 conjugates synthesized with different Ac-PEG-NHS to LM111 ratios.   
2.2.3 Cell Isolation and Culture 
Cells isolated from the porcine NP have a unique notochordal-like phenotype, and 
were therefore used to evaluate both PEG-LM111 conjugate bioactivity and for in vitro 
and in vivo cell delivery experiments.  Lumbar spines were obtained from pigs shortly 
after sacrifice (L1–L5, 4-7 months, Nahunta Pork Outlet, Raleigh NC).  Cells were isolated 
from the NP regions of IVDs by enzymatic digestion [171] and cultured in monolayer for 
3 – 7 days in culture media (Ham’s F-12 media supplemented with 10% fetal bovine serum 
(FBS), 10 mM HEPES, 100 U/ml penicillin, and 100 U/ml streptomycin) prior to 
experiments.  For control studies, cells from a lung epithelial cell line (WI26VA4, ATCC 
No. CCL-95-1) were cultured in monolayer (37°C, 5% CO2, 20% O2) with media changes 
every 3-4 days (Dulbecco’s Modified Eagle’s Medium supplemented with 10% FBS, 10 
mM HEPES) prior to experiments. 
2.2.4 PEG-LM111 Conjugate Bioactivity in 2D  
To evaluate cell attachment to PEG-LM111 conjugates, wells of 96-well plates were 
coated with PEG-LM111 conjugates synthesized with various ratios of Ac-PEG-NHS to 
LM111 at 5, 10, and 25 µg/ml LM111 by overnight incubation at 4°C.  Coated wells were 
blocked with 3.75% bovine serum albumin (BSA) for 3 hours at 37°C to prevent non-
specific adhesion.  LM111 coated wells and BSA only coated wells were used as positive 
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and negative controls, respectively.  Porcine NP cells in monolayer were detached using 
trypsin/EDTA, washed with trypsin neutralizing solution and resuspended in serum free 
media.  Cells (4000 cells/well) were allowed to adhere to the LM111 and PEG-LM111 
conjugate coated surfaces for 2 hours at 37°C.  Wells were rinsed with serum free media 
to remove non-adherent cells, and the number of adherent cells per well was determined 
using CellTiterGlo® (Promega Corporation, Madison, WI) luminescent cell viability 
reagent.   Differences in attachment numbers to PEG-LM111 conjugates at 25 µg/ml LM111 
were detected via ANOVA with Tukey’s post hoc test (p <0.05, n=3 separate cell 
isolations).   
To determine if PEG-LM111 conjugate maintains the ability to induce ERK 
activation upon cell adhesion, wells of 6-well tissue culture plates were coated by 
overnight incubation at 4°C with 20 µg/ml LM111 or PEG-LM111 that had been PEGylated 
at the highest ratio of Ac-PEG-NHS shown to promote cell attachment at levels similar to 
native protein.  All wells were blocked with 3.75% BSA to prevent non-specific adhesion. 
Cells from a lung epithelial cell line WI26VA4 (ATCC No. CCL-95-1) that had been 
cultured to confluence, then serum deprived for 24 hours, were seeded onto LM111 or 
PEG-LM111 conjugate coated surfaces (500,000 cells/well).  WI26VA4 cells cultured in 
suspension served as negative controls. After 30 and 60 minutes, cells were lysed with ice 
cold cell lysis buffer containing protease and phosphatase inhibitors (RIPA, Cell Signaling 
Technologies, Danvers, MA), spun down at 4°C, and cell lysates were stored at -80°C. 
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Total protein concentration in each of the cell lysates was determined using the BCA 
Protein Assay (Thermo Scientific, Waltham, MA). All lysates were diluted in cell lysis 
buffer to equal concentrations of total protein and a phospho-ERK ELISA (Cell Signaling 
Technologies) was used to detect relative levels of phosphorylated ERK. 
 
2.2.5 Photocrosslinked PEG-LM111 Hydrogel Preparation  
PEG-LM111 hydrogels were formed by mixing PEG-LM111 conjugate with 
additional PEG-diacrylate (PEG-DA), and crosslinking via exposure to UV light (Figure 
8).  Briefly, PEG-DA (10kDa, Creative PEGworks) was weighed, sterilized by exposure to 
UV light (265nm) for 30 minutes, and transferred to sterile eppendorf tubes.  To form PEG-
LM111 hydrogels, varying amounts of PEG-LM111 conjugate (0 – 1000 µg/ml) and 10 kDa 
PEG-DA (2 – 10% (w/v)) were mixed, injected into custom molds [172] using a 22 gauge 
needle and 1 ml syringe and polymerized upon 5minute  exposure to UV light (3-4 
mW/cm2) in the presence of 0.1% (w/v) photoinitiator (Irgacure 2959®, Ciba Speciality 
Chemicals, Tarrytown, NY). 
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Figure 8. Schematic of photocrosslinkable PEG-laminin (PEG-LM111) 
hydrogel preparation.  PEG-LM111 conjugates were synthesized by the addition of ac-
PEG-NHS to introduce functional acrylate groups for crosslinking.  Conjugates were 
mixed with additional PEG-DA and crosslinked via exposure to UV light to form 
PEG-LM111 hydrogels of varying stiffness and LM111 concentration.    
 
2.2.6 LM111 Distribution in PEG-LM111 Hydrogels 
Immunostaining of PEG-LM111 hydrogels was performed to evaluate effects of 
Ac-PEG-NHS to LM111 ratio used in conjugate synthesis on the amount of protein 
incorporated into PEG-LM111 hydrogels.  PEG-LM111 hydrogels were crosslinked as 
described above to obtain 4 different hydrogel formulations containing 5% (w/v) PEG-DA 
and 200 µg/ml PEG-LM111 conjugate synthesized at either 10:1, 25:1, 100:1 or 500:1 molar 
ratio of Ac-PEG-NHS to LM111.   Blank 5% (w/v) PEG-DA hydrogels and 5% (w/v) PEG-
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DA gels mixed with 200 µg/ml LM111 prior to crosslinking were photocrosslinked in the 
same manner as compared to other groups.  Samples were frozen in Tissue-Tek® O.C.T. 
compound (Sakura Finetek USA, Torrance, CA) and cryosectioned to obtain 20 µm thick 
sections.  For each gel formulation, 6-8 sections were stained with a primary antibody 
specific to the γ chain of LM111 (L9393, Sigma-Aldrich, St. Louis, MO), followed by a goat 
anti-rabbit secondary antibody (Alexa Fluor 488®, Invitrogen, Carlsbad, CA).  Samples 
were imaged by confocal microscopy to obtain 3 image fields per section (Zeiss LSM 510, 
10x objective; Zeiss, Jena, Germany).  Quantitative image analysis was performed using a 
custom written MATLAB script.  Briefly, images were converted to grayscale, thresholded 
by subtracting out a blank PEG-DA image, and mean fluorescence intensity per image 
field was obtained as a measure of the amount of LM111 incorporated into each hydrogel.  
Mean intensity values were normalized to that of hydrogels containing entrapped LM111.  
A one-way ANOVA was performed to analyze mean fluorescence intensity per image 
field, using Tukey’s post hoc test to detect differences between PEG-LM111 conjugates 
synthesized with different ac-PEG-NHS to LM111 ratios (p<0.05, n = 6 or 8 separate 
sections per hydrogel formulation, 3 images per section).     
 
2.2.7 PEG-LM111 Conjugate Bioactivity in 3D 
Preliminary cell encapsulation experiments were performed to evaluate PEG-
LM111 conjugate bioactivity and to assess the ability of LM111 to promote NP cell survival 
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in 3D culture under low cell density, serum free conditions.  Primary porcine NP cells 
were encapsulated in blank PEG-DA hydrogels (6% PEG-DA), PEG-DA hydrogels with 
unmodified LM111 that had been mixed in prior to crosslinking (6% PEG-DA, 200 µg/ml 
entrapped LM111), or PEG-LM111 hydrogels (6% PEG-DA, 200 µg/ml PEGylated LM111).  
Briefly, porcine NP cells were pelleted and resuspended in hydrogel precursor solutions 
(2 million cells/ml), injected into custom injection molds, and polymerized upon exposure 
to UV light in the presence of 0.1% (w/v) photoinitiator (Irgacure 2959®) as described 
above.  After polymerization, cylindrical constructs were cored using a 6mm biopsy 
punch and cultured in 24 well plates in serum free media (F-12 supplemented with 10 mM 
HEPES, 100 U/ml penicillin, and 100 U/ml streptomycin) with gentle agitation. At each 
time point, cell-gel constructs (n=5 per formulation) were submerged in live/dead staining 
solution (Invitrogen) and incubated at 37°C for 30 minutes.  Cell viability and distribution 
were visualized by confocal microscopy on days 0 and 7.  Images (4 per cell-gel construct) 
were analyzed using ImageJ (NIH) to determine the percent of live cells present at each 
time point.  Differences in cell viability amongst hydrogel formulations were analyzed via 
two-way ANOVA (time point, hydrogel formulation) with Tukey’s post hoc test (p<0.05, 
n=5 per hydrogel formulation).   
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2.3 Results  
2.3.1 Degree of LM111 Modification 
PEG-LM111 conjugates with functional acrylate groups for crosslinking were 
synthesized via amine reactive NHS groups (Figure 9).  Degree of LM111 modification, as 
measured by the reduction in number of reactive amines in each PEG-LM111 conjugate, 
significantly increased with increasing ratios of Ac-PEG-NHS to LM111 in the reaction 
solution (Figure 9).  A minimum 25-fold molar excess of Ac-PEG-NHS over LM111 in the 
PEGylation reaction was necessary to detect protein modification (6%) using the TNBS 
assay.  A 500-fold molar excess of Ac-PEG-NHS resulted in 39% LM111 modification, 
which was significantly higher (ANOVA, p<0.001) than that of PEG-LM111 conjugates 
synthesized at 10-fold, 25-fold or 100-fold molar excess Ac-PEG-NHS over LM111.     
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Figure 9. PEG-LM111 conjugate synthesis and degree of modification (%).  (A) 
Conjugation of PEG molecules to laminin via amine reactive NHS groups.  (B) Degree 
of modification of LM111 calculated from LM111 and PEG-LM111 conjugate 
absorbance at 340nm using TNBS assay.  Degree of modification increased with 
increasing molar excess of Ac-PEG-NHS in the PEGylation reaction (mean ± SEM, 
n=3, conditions labeled with different letters significantly different, p<0.01).    
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2.3.2 PEG-LM111 Conjugate Bioactivity in 2D  
To determine the relationship between the degree of LM111 modification and level 
of cell attachment, porcine NP cell attachment to PEG-LM111 conjugates with varying 
degrees of modification was assessed.  Results for NP cell adhesion to PEG-LM111 
conjugates demonstrated decreased cell attachment with increasing molar excess of Ac-
PEG-NHS over LM111 used in conjugate synthesis, as compared to NP cell attachment to 
unmodified LM111 (Figure 10A). Cell attachment was significantly reduced (ANOVA, 
p<0.001) for conjugates synthesized with large molar excesses of PEG (100:1 or 500:1); 
however, cell attachment numbers for PEG-LM111 conjugate synthesized with a 25:1 ratio 
of Ac-PEG-NHS to LM111 were greater than 89% of values for NP cell attachment to 
native LM111.  Therefore, PEG-LM111 conjugate synthesized at a 25-fold molar excess of 
Ac-PEG-NHS over LM111, which corresponds to 6% degree of modification by TNBS, was 
used for all subsequent experiments.   
To further verify bioactivity of PEG-LM111 conjugate with a low degree of 
modification, we investigated activation of the MAPK/ERK signaling pathway 
subsequent to cell attachment to LM111 and PEG-LM111 conjugate.  Since it has been 
shown that cell attachment to LM111 leads to ERK activation in a lung epithelial cell line 
(WI26VA4) [173], we hypothesized that a PEG-LM111 conjugate capable of maintaining 
levels of cell adhesion similar to that of native LM111 would also support ERK 
phosphorylation.  As shown in Figure 10B, LM111 induced a 3-fold increase in 
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phosphorylated-ERK over cells cultured in suspension after 30 minutes and a 1.6-fold 
increase after 60 minutes.  PEG-LM111 conjugate induced similar levels of 
phosphorylated ERK as compared to LM111 with 2.8-fold and 1.7-fold higher levels of 
ERK phosphorylation over negative controls after 30 and 60 minutes, respectively. 
 
 
 
Figure 10. Bioactivity of PEG-LM111 conjugates.  (A) Porcine NP cells were 
allowed to attach to LM111 and PEG-LM111 conjugates for 2 hours.  NP cell 
attachment to PEG-LM111 conjugates decreased with increasing molar excess Ac-
PEG-NHS in the PEGylation reaction (cell attachment levels normalized to NP cells 
on 25 µg/ml LM111, mean ± SEM, n=3, conditions labeled with different letters 
significantly different, p<0.04).  (B)  LM111 induced ERK activation in a lung 
epithelial cell line. Cells from a lung epithelial cell line (WI26VA4) were seeded onto 
LM111 and PEG-LM111 conjugate coated surfaces, or cultured in suspension. After 30 
and 60 minutes, cells were lysed and levels of phosphorylated ERK in cell lysates 
were compared using ELISA. 
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2.3.3 LM111 Distribution in PEG-LM111 Hydrogels 
Immunostaining of PEG hydrogels was performed to determine the effect of Ac-
PEG-NHS to LM111 ratio used in the PEGylation reaction on the amount of LM111 
incorporated into each hydrogel formulation.  Immunostaining results demonstrate that 
the ratio of PEG to LM111 used in PEG-LM111 conjugate synthesis affects the amount of 
LM111 incorporated into the hydrogel (Figure 11).  Fluorescence images show more 
intense staining for LM111 in hydrogels containing PEG-LM111 conjugate synthesized 
with a high ac-PEG-NHS PEG to LM111 ratio (500:1) as compared to those containing 
PEG-LM111 conjugates synthesized with a low ratio of ac-PEG-NHS to LM111 (25:1) or 
physically entrapped LM111 (Figure 11).  Mean fluorescence intensity per image field 
significantly increased with increasing molar excess ac-PEG-NHS in PEG-LM111 
conjugate synthesis (ANOVA, p<0.03).  Very high levels of PEGylation (500:1) resulted in 
~3.5 times more intense staining for LM111 in PEG-based hydrogels, as compared to PEG-
DA hydrogels containing entrapped unmodified LM111; however, this degree of LM111 
modification has been shown to inhibit NP cell adhesion to the PEGylated protein.  
Therefore, PEG-LM111 conjugate synthesized with a low molar excess ac-PEG-NHS (25:1) 
was utilized in all subsequent cell entrapment studies.   
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Figure 11. Immunostaining of PEG-LM111 hydrogels.  (A)  Mean fluorescence 
intensity per image field in PEG hydrogels containing entrapped LM111, or PEG-
LM111 hydrogels containing PEG-LM111 conjugates synthesized with various Ac-
PEG-NHS to LM111 ratios.  Fluorescence intensity increased with increasing molar 
excess of Ac-PEG-NHS:LM111 ratio in the PEG-LM111 conjugate synthesis reaction 
(mean ± SEM, n ˃ 6 sections, 3 images per section, conditions labeled with different 
letters significantly different, p<0.03).  (B) Representative images of LM111 
immunostaining in PEG hydrogels.  Scale bars = 100 µm. 
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2.3.4 PEG-LM111 Conjugate Bioactivity in 3D  
To verify the bioactivity of crosslinked PEG-LM111 conjugate, and to assess the 
ability of LM111 to promote NP cell survival in 3D PEG hydrogels under low cell density, 
serum free conditions, primary porcine NP cells were entrapped in PEG-DA hydrogels 
containing the same concentration of PEG-LM111 conjugate or entrapped unmodified 
LM111 and cultured for 7 days.  Cells remained viable through photocrosslinking, with 
>82% cell viability for all hydrogel formulations on day 0.  Cell viability was significantly 
lower after 7 days in culture for all hydrogel formulations (p<0.001); however NP cell 
survival on day 7 was significantly higher in PEG hydrogels containing entrapped LM111 
or PEG-LM111 conjugate as compared to blank PEG-DA gels (Tukey’s, p<0.02) (Figure 
12). 
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Figure 12. Cell viability in PEG hydrogels.  (A) NP cell viability in PEG-based 
hydrogels after 0 and 7 days of culture in serum free media.  Percent viability 
determined by counting the number of live cells as a percentage of total cells in 
images of hydrogels stained with Live/Dead viability assay (mean ± SEM, n=5, 
conditions labeled with different letters significantly different, p<0.02).  (B) 
Representative images of Live/Dead stained cell-laden hydrogels, where live cells 
fluoresce green and dead cells fluoresce red.  Scale bars = 100 µm. 
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2.4 Discussion 
Laminin presenting substrates have previously been shown to promote the 
morphology and phenotype of immature NP cells in vitro, and to promote increased cell 
attachment and elevated glycosaminoglycan synthesis for primary NP cells in culture [33, 
95].  For these reasons, LM111 was PEGylated to introduce functional acrylate groups onto 
the native protein for crosslinking.  Conjugation of the laminin protein, LM111 to synthetic 
PEGs was performed with varying levels of protein modification in order to identify a 
formulation that could maintain LM111 functionality, and appropriate cell-laminin 
interactions.  As expected, the degree of laminin modification increased with increasing 
molar excess of Ac-PEG-NHS in the conjugate synthesis reaction, up to a maximum value 
of 40% primary amine modification with a 500-fold molar excess of Ac-PEG-NHS, as 
measured by the TNBS colorimetric methods.  While TNBS allows for determination of 
the average degree of protein modification by PEG, it does not provide information on 
the heterogeneity of the PEGylated protein or the sites of PEGylation [174].   Therefore, it 
was necessary to evaluate PEG-LM111 conjugate bioactivity to assess whether bound PEG 
chains hinder cell – LM111 interaction.    
Primary NP cell adhesion to PEG-LM111 conjugates significantly decreased with 
increasing degree of PEGylation, with no cells adhering to PEG-LM111 conjugate with the 
highest degree of modification.  This finding was expected as PEGylation of therapeutic 
compounds has been shown to modify their structure and bioactivity [175].  Nevertheless, 
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low levels of PEGylation (up to 25:1 Ac-PEG-NHS to LM111) did not significantly reduce 
NP cell adhesion to PEG-LM111 conjugates, nor inhibit MAPK/ERK activation upon 
binding to the modified protein.  This low level of LM111 modification still enabled the 
PEG-LM111 conjugate to participate in a photocrosslinking reaction that was shown to be 
effective in promoting LM111 distribution in PEG-LM111 hydrogels.  Together, these 
findings demonstrate that LM111 PEGylation via a heterobifunctional Ac-PEG-NHS 
allows for the additional of functional acrylates groups onto native LM111 without 
significantly altering the protein’s ability to mediate cellular function. 
Increasing the degree of LM111 PEGylation (ratio of Ac-PEG-NHS to LM111 in the 
PEGylation reaction) was shown to significantly increase the amount of LM111 
incorporated into PEG-LM111 hydrogels.  This is likely due to an increased number of 
acrylate groups on LM1111 that can participate in the photocrosslinking reaction.  Low 
levels of PEGylation, however, were not found to significantly increase the amount of 
protein incorporated into PEG-LM111 hydrogels as compared to physically entrapped 
LM111.  This finding suggests that a threshold level of protein modification that must be 
achieved in order for PEG-LM111 to become part of the hydrogel backbone.  While 
increased ligand density within PEG-LM111 hydrogels is desirable, cell attachment 
results demonstrate that a high degree of LM111 modification by Ac-PEG-NHS 
significantly reduces its bioactivity and inhibits immature NP cell adhesion to the 
modified protein.  Therefore, PEG-LM111 conjugate synthesized with a low level of 
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PEGylation (25:1 Ac-PEG-NHS to LM111) was chosen and evaluated for its ability to 
promote NP cell survival in 3D.   
While 2D studies afford very good control of the substrate stiffness and ECM 
chemistry, culturing cells within a 3D matrix is much more representative of the native 
environment.  In preliminary studies, the majority of NP cells cultured in PEG-only 
hydrogels at very low cell densities under serum free conditions died over 7 days 
(Appendix A).  Studies were performed to determine if LM111 could act as a survival 
ligand under these culture conditions.  As expected, the majority of primary NP cells 
encapsulated in PEG-based hydrogels at a very low cell density and cultured under 
serum-free conditions died over 7 days in culture; however, significantly more cells 
survived when encapsulated in hydrogels containing LM111 as compared to PEG-only 
gels.  It is well known that LM111 promotes cell survival for a number of cell types in vitro 
[139]; therefore, this finding suggests that LM111 may be a survival ligand for primary 
NP cells.  Viability was similar for cells cultured in PEG-LM111 hydrogels and PEG 
hydrogels containing an equal concentration of entrapped, unmodified LM111.  This 
finding suggests that PEGylated LM111 retains the bioactivity of the native protein in 3D, 
and that survival is mediated by cell-LM111 interactions irrespective of ligand 
presentation.   Overall, cell viability was likely affected by the small mesh size of PEG 
hydrogels formed by photopolymerizing PEG-DA, which limits nutrient and waste 
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diffusion in cultured hydrogels [176], and may inhibit cell-cell interactions when cells are 
encapsulated at very low densities. 
 
2.5 Conclusion 
Overall, these findings demonstrate that PEG-LM111 conjugates synthesized 
using a PEG to LM111 ratio of 25:1 maintain their ability to support NP cell attachment 
and cell survival in 3D hydrogels in a manner similar to unmodified LM111. At this ratio, 
immunostaining results suggest that LM111 incorporation into photocrosslinked PEG-DA 
hydrogels is increased compared to PEG-DA gels containing physically entrapped 
LM111. Together, these findings demonstrate that the addition of functional acrylate 
groups onto native LM111 through the use of a heterobifunctional Ac-PEG-NHS allows 
for increased protein incorporation into PEG-DA hydrogels without significantly altering 
the proteins ability to mediate cellular function. Therefore, LM111 functionalized PEG 
hydrogels may be useful for promoting IVD cell-matrix interactions while promoting the 
rounded cell morphology and unique phenotype of IVD cells. 
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3. Effects of Photocrosslinkable PEG-LM111 Hydrogel 
Properties on NP Cell Phenotype In Vitro 
3.1 Introduction 
A variety of synthetic, natural and hybrid materials have been investigated as 
scaffolds for NP regeneration [177], mainly in the form of hydrogels, which mimic the 
highly hydrated nature of the native NP.  Natural components of the ECM such as 
hyaluronan [111, 112, 178], collagen [101, 103], and fibrin [103], and naturally derived 
polysaccharides such as alginate [97, 100, 103], chitosan [116-118], and agarose [103], have 
all been studied as potential scaffolds for NP tissue engineering.  Although these naturally 
derived materials mimic many features of the native ECM, few peptide and protein 
functionalized scaffolds have been developed that can direct biological responses of cells 
for NP regeneration [28].   One limitation of using natural polymers for tissue engineering 
is that their mechanical properties can not easily be controlled.  To overcome this, hybrid 
biomaterials of both natural and synthetic materials [113, 118, 119, 178], and natural 
polymers modified to contain functional groups that allow for photocrosslinking [102, 
110] have been explored as potential scaffolds for NP tissue engineering.    
Few studies have attempted to evaluate a scaffold for its ability to maintain or 
promote the immature NP cell phenotype.  This is likely due to the lack of specific markers 
that distinguish immature NP cells from smaller more chondrocyte-like NP cells, anulus 
fibrosus cells, and articular chondrocytes.  A number of recent studies have focused on 
defining the NP cell phenotype by evaluating biomarker expression in immature or non-
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degenerate NP cells as compared to that in degenerate NP cells, anulus fibrosus cells or 
articular chondrocytes [84, 85, 87, 90, 179].  Laminin binding integrin subunits α3, α6 and 
β4 have been shown to be uniquely expressed in cells of the immature NP [30, 84].  N-
cadherin has been shown to be more highly expressed in NP cells as compared to articular 
chondrocytes [85] and AF cells [88].  Finally, cytokeratin 8, an intermediate filament 
protein, is known to be expressed in notochordal-like disc cells [74] and more recently has 
been shown to be differentially expressed in NP cells [85, 90]. These findings provide 
useful biomarkers for choosing those scaffold biochemical and physical properties that 
can promote or maintain an immature NP cell phenotype.   
In this chapter, photocrosslinkable PEG-LM111 hydrogels developed in Chapter 2 
were used to investigate the effect of laminin ligand presentation and matrix stiffness on 
immature NP cell phenotype.  We evaluated immature NP cell organization and 
proteoglycan synthesis when cells were cultured on top of PEG-LM111 hydrogels.   
Additionally, we describe here the effects of hydrogel stiffness and LM111 concentration 
on NP cell metabolism and NP phenotypic marker expression, including integrin subunits 
α3, α6, and β1, as well as cytokeratin 8, when cells were cultured within 3D PEG-LM111 
hydrogels.   
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3.2 Methods  
3.2.1 Photocrosslinked PEG-LM111 Hydrogel Mechanical Properties  
PEG-DA was dissolved in PEG-LM111 conjugate solution (synthesized at 25-fold 
molar excess ac-PEG-NHS) and 0.1% Irgacure 2959® solution to obtain 6 different 
hydrogel formulations (5 or 10% PEG-DA and 0, 100 or 500 µg/ml PEG-LM111 conjugate).  
Hydrogel precursor solutions were injected into a custom injection mold as described 
above.  After crosslinking, 6 mm diameter samples were cored and allowed to equilibrate 
in PBS before testing.  All samples were tested in oscillatory shear in a 37°C, temperature-
controlled phosphate buffered saline bath using a stress controlled rheometer (AR-G2, TA 
Instruments, New Castle, DE).  Immediately prior to testing, each gel was digitally 
photographed to obtain the sample diameter. Samples were places in the center of a 
preheated sintered steel lower platen (8 mm diameter) and subjected to a compressive tare 
load (1-2g) with a sintered steel upper platen (8 mm diameter).  After equilibrating, 
samples were subjected to a 10% compressive strain followed by 20 minute relaxation.  
Samples were subjected to an oscillatory torsional strain (1 – 20 rad/s) with a maximum 
amplitude of shear strain (γ, 0.01).  The complex shear moduli (|G*|) were reported at a 
frequency of 10 rad/sec.  Differences in shear moduli amongst hydrogels with varying 
concentrations of PEG-DA and PEG-LM111 conjugate were analyzed via two-way 
ANOVA with Tukey’s post hoc test (p<0.05, n=5 per hydrogel formulation).   
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3.2.2 Cell Isolation and Culture  
Porcine NP cells were used for study as the majority of cells isolated from the 
immature porcine NP are known to resemble notochordally-derived NP cells [84].  
Lumbar spines were obtained from pigs shortly after sacrifice (L1–L5, 4-7 months, 
Nahunta Pork Outlet, Raleigh NC).  Cells were isolated from the NP regions of IVDs by 
enzymatic digestion [171] and cultured in monolayer for 1 – 7 days in culture media (F-12 
media supplemented with 10% Fetal Bovine Serum (FBS), 10 mM HEPES, 100 U/ml 
penicillin, and 100 U/ml streptomycin) prior to experiments.   
 
3.2.3 Primary NP Cell Behavior in PEG-LM111 Hydrogels in 3D   
Primary porcine NP cells (20 million/ml) were mixed with PEG-DA (5 or 10%), 
PEG-LM111 conjugate (0, 100, or 500 µg/ml) and 0.1% Irgacure 2959® for a total of 6 
material formulations.  Precursor solutions were injected into custom molds and 
crosslinked by UV exposure (5 min, 3-4 mW/cm2).  Samples were cored using a 3mm 
biopsy punch (n=9 per formulation) and cultured in vitro (F-12 media supplemented with 
10% FBS, 10 mM HEPES, 100 U/ml penicillin, and 100 U/ml streptomycin) with gentle 
agitation.  Fifty percent volume media changes were performed every 3-4 days for 28 
days.   
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3.2.3.1 Measurement of Media Metabolites 
Media aliquots from NP cell-PEG samples, and media from wells containing no 
PEG or cells were obtained on day 4 and stored at -80°C until further use.  On the day of 
analysis, media aliquots were thawed and filtered through a 10 kDa MW cut-off 
centrifugal filter device (Nanosep, Pall Life Sciences, East Hills, NY).  Fifteen microliter 
samples were then transferred to plastic vials, briefly spun, and analyzed for glucose, 
lactate, and pyruvate concentrations on a CMA 600 microdialysis analyzer (CMA 
Microdialysis, North Chelmsford, MA).  The difference between each metabolite 
concentration in media collected from wells containing cell-laden PEG hydrogel samples 
and day 0 media that had been cultured for the same period was calculated for each 
sample. For each metabolite, differences amongst hydrogel formulations were analyzed 
via two-factor ANOVA (% PEG-DA, PEG-LM111 conjugate concentration) with Tukey’s 
post hoc test (p<0.05, n=9 per hydrogel formulation).   
 
3.2.3.2 Phenotypic Marker Immunostaining  
Cell-laden hydrogel samples were immunostained for N-cadherin, cytokeratin 8, 
integrin α3, and integrin α6 to evaluate the effects of PEG-LM111 hydrogel stiffness and 
LM111 concentration on NP cell phenotype.  On day 28, samples (n=3 per formulation) 
were embedded in Tissue Tek® OCT embedding compound and flash frozen in liquid 
nitrogen.  Samples were stored at -80°C until further use.  Frozen cell-laden PEG-LM111 
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hydrogel sections (8 µm thick) were fixed in 4% paraformaldehyde (10 minutes at room 
temperature) for labeling with antibodies detecting N-cadherin and cytokeratin 8.  For 
labeling integrin subunits α3 and α6, sections were fixed in acetone (10 minutes at -20°C).  
Following fixation, all sections were incubated with blocking solution (3.75% BSA/5% goat 
serum) for 45 minutes at room temperature, and then incubated for 2 hours at room 
temperature with one of the following primary antibodies: N-cadherin (ab12221, Abcam, 
Cambridge, MA), cytokeratin 8 (SM3079P, Acris Antibodies, San Diego, CA), integrin α3 
(AB1920, EMD Millipore, Billerica, MA), and integrin α6 (555734, BD Biosciences, San 
Jose, CA).  Sections were washed twice with PBS and incubated with secondary antibody 
(AlexaFluor 488, Molecular Probes, Eugene, OR) for 30 minutes in blocking solution.   
Control sections were incubated with appropriate IgG controls or secondary antibody 
alone as a negative control for polyclonal antibodies.  All sections were counterstained 
with propidium iodide (Sigma) at room temperature for 30 minutes to label cell nuclei.  
Sections were imaged via confocal microscopy (Zeiss, 20X NA 0.5 objective).  Digital 
images acquired for each cell-laden hydrogel (n=9 images per hydrogel formulation) were 
evaluated by two blinded graders coming to consensus for fluorescence staining 
uniformity with the following ordinal scale: 0 (no stain), 1 (<10% cells positively stained), 
2 (10 – 50% cells positively stained), 3 (>50% of cells positively stained) for each image.  
Grades of immunohistochemical staining were analyzed for differences amongst 
hydrogel formulations using Kruskal-Wallis one-way ANOVA (p<0.05).  When 
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significance was observed, post-hoc Wilcoxon tests with Bonferroni correction for 
multiple comparisons were performed to detect differences amongst hydrogel 
formulations.   
 
3.2.4 Primary NP Cell Behavior on PEG-LM111 Hydrogels in 2D  
3.2.4.1 sGAG Production  
Primary porcine NP cells (88,000 cells/cm2) were seeded onto PEG-LM111 
hydrogels of varying concentrations of PEG (2 or 10% PEG-DA) and LM111 (0 or 1 mg/ml 
LM111) for a total of four hydrogel substrate formulations (n=6 per substrate).  Primary 
NP cells (88,000 cells/cm2) were also seeded onto a laminin-rich ECM-derived basement 
membrane extract (BME) product (Trevigen, Inc; growth factor-reduced, 13.8 mg/mL) as 
a positive control.  BME is a solubilized basement membrane preparation extracted from 
the Engelbreth-Holm-Swarm (EHS) mouse sarcoma tumor, which contains high 
concentrations of several ECM proteins: LM111 (~60%), type IV collagen (~30%), entactin 
(~8%), and heparin sulfate [180].  When polymerized into a “thick” gel, BME provides a 
laminin-rich environment of stiffness close to that of the native NP tissue (0.2 kPa) [33, 
178, 181].  Cells were cultured on top of each hydrogel formulation for 4 days in culture 
media, after which sGAG production by NP cells was analyzed with dimethylmethylene 
blue (DMMB) spectrophotometric method as previously described [33].  All media 
overlay from culture samples was collected, while cells and gel proteins remaining in 
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corresponding wells after removal of media were digested in papain solution (125 µg/ml 
in PBS with 5 mM EDTA and 5mM cysteine, 2 hours, 65°C). Samples from control wells 
(n=2 per substrate) which only contained gels, were collected and processed similarly. 
sGAG content was measured by mixing samples with DMMB dye and absorbance (535 
nm) was measured on a plate reader (Perkin-Elmer Enspire Multimode Reader, Waltham, 
MA). sGAG concentrations were calculated from a standard curve prepared from 
chondroitin-4-sulfate (Sigma). Total concentration of sGAG (media overlay plus cell 
digest) was normalized to total DNA content (Quant-iT PicoGreen dsDNA Kit, 
Invitrogen) for each sample. Differences in sGAG production (sGAG/DNA) across 
hydrogel substrate formulations were analyzed via one-way ANOVA with Tukey’s post 
hoc analysis (p<0.05, n=6 per substrate formulation). 
 
3.2.4.2 Cell Morphology  
Immature porcine NP cells (88,000 cells/cm2) were seeded onto PEG only 
hydrogels (2 or 10% PEG-DA), and PEG-LM111 hydrogels (2 or 10% PEG-DA, 1 mg/ml 
LM111) as described above (n=6 per substrate formulation). The same number of NP cells 
were seeded onto BME gels for comparison. After 4 days of culture upon gels, NP cells 
were fixed with 4% paraformaldehyde (Electron Microscopy Sciences, Hatfield, PA; 
diluted in DPBS) for 20 minutes at room temperature. NP cells were then washed with 
DPBS and labeled for actin (Alexafluor-488 phalloidin, Invitrogen, 200x dilution in DPBS 
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for 30 minutes at room temperature) followed by a cell nuclei stain (propidium iodide, 
Sigma, 0.33 mg/ml for 20 minutes at room temperature). Immediately after staining, NP 
cells were imaged via confocal microscopy (Zeiss LSM510, 10x magnification). 
 
3.3 Results  
3.3.1 Photocrosslinked PEG-LM111 Hydrogel Mechanical Properties 
PEG-LM111 hydrogels were tested in oscillatory torsional shear to investigate the 
effects of PEG-LM111 conjugate concentration and PEG-DA concentration on hydrogel 
mechanical properties.  Photocrosslinked PEG-LM111 hydrogel stiffness (|G*|) 
significantly increased with increasing PEG-LM111 conjugate concentration for gels 
formed with either 5% or 10% PEG-DA (two-way ANOVA, p<0.03) (Figure 13).  PEG-
LM111 hydrogel stiffnesses (|G*|) were significantly higher in gels containing 10% PEG-
DA as compared to 5% PEG-DA (two-way ANOVA, p<0.001). 
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Figure 13. Physical characterization of photocrosslinked PEG-LM111 
hydrogels.   Torsional shear stiffness (|G*|, 5 rad/s) of 5% (w/v) and 10% PEG (w/v) 
hydrogels (mean ± SEM, n=5, conditions labeled with different letters significantly 
different, p<0.03). 
 
 
3.3.2 Primary NP Cell Behavior in PEG-LM111 Hydrogels 3D 
3.3.2.1 Measurement of Media Metabolites 
Media aliquots from NP cell-laden PEG-LM111 hydrogels were analyzed for 
glucose, lactate and pyruvate to evaluate the effects of hydrogel stiffness and LM111 
concentration on NP cell metabolism.  Lactate and pyruvate levels were significantly 
affected by PEG-LM111 conjugate concentration (two-way ANOVA, p<0.001); however, 
glucose consumption was similar for all material formulations.  Cells cultured in gels 
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containing 100 µg/ml PEG-LM111 conjugate consumed more pyruvate and produced 
more lactate over the 4 day culture period than cells cultured in gels containing 0 or 500 
µg/ml PEG-LM111 conjugate (Figure 14). 
 
 
Figure 14. Media metabolite concentrations (change from day 0 media) in 
media aliquots obtained from NP cell-PEG constructs.  Cells in gels containing 100 
µg/ml LM111 consumed significantly more pyruvate and produced significantly more 
lactate than cells in all other hydrogel formulations (mean ± SEM, n=9, p<0.01).   
  
3.3.2.2 Phenotypic Marker Immunostaining 
Cytokeratin 8, N-cadherin, integrin α3 and integrin α6 expression by NP cells 
cultured in PEG-LM111 hydrogels was evaluated by immunohistochemical analysis 
(Table 3, Figure 15).  The percentage of cells staining positively for cytokeratin 8 was 
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significantly higher in softer PEG-LM111 gels containing 5% PEG and 100 or 500 µg/ml 
LM111 (one-way ANOVA, Bonferroni correction, p<0.003) as compared to stiffer gels 
containing 10% PEG and equivalent amounts of LM111, and PEG-only (no LM111) gels.  
N-cadherin expression was significantly higher for NP cells cultured in PEG-LM111 
hydrogels containing 5% PEG and high concentrations of LM111 (500 µg/ml) (one-way 
ANOVA, Bonferroni correction, p<0.003) as compared to cells cultured in all other 
hydrogel formulations.   Integrin α3 expression varied significantly with hydrogel 
formulation (p<0.0001) with the highest percentage of cells staining positively for cells 
cultured in PEG-LM111 gels containing 5% or 10% PEG and 100 µg/ml LM111, or 5% PEG 
and 500 µg/ml LM111.  Very low or no staining of integrin α6 was observed for all 
hydrogel formulations.   
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Table 3. Frequency of phenotypic marker immunohistochemical scores for NP 
cell-laden hydrogels of varying formulations. 
N-cadherin 
Score 
5% PEG 10% PEG 5% PEG 10% PEG 5% PEGa 10% PEG 
0 µg/ml LM111 100 µg/ml LM111 500 µg/ml LM111 
0 4 0 6 4 0 6 
1 5 8 1 4 1 3 
2 0 1 2 0 4 0 
3 0 0 0 0 4 0 
cytokeratin 8 
score 
5% PEG 10% PEG 5% PEGb 10% PEG 5% PEGb 10% PEG 
0 µg/ml LM111 100 µg/ml LM111 500 µg/ml LM111 
0 0 0 0 0 0 0 
1 7 6 1 6 0 8 
2 2 3 2 3 4 1 
3 0 0 6 0 5 0 
integrin α3 
score 
5% PEG 10% PEG 5% PEGb 10% PEG 5% PEGc 10% PEG 
0 µg/ml LM111 100 µg/ml LM111 500 µg/ml LM111 
0 1 0 0 0 0 0 
1 5 7 0 4 1 4 
2 0 2 1 3 4 5 
3 0 0 8 2 4 0 
integrin α6d 
score 
5% PEG 10% PEG 5% PEG 10% PEG 5% PEG 10% PEG 
0 µg/ml LM111 100 µg/ml LM111 500 µg/ml LM111 
0 5 6 4 8 9 8 
1 1 3 2 1 0 1 
2 0 0 0 0 0 0 
3 0 0 0 0 0 0 
a Significantly different from hydrogels containing 5% PEG (0 or 100 µg/ml LM111) and 
formulations containing 10% PEG (0, 100 or 500 µg/ml) (p<0.003) 
b Significantly different from formulations containing 10% PEG (0, 100 or 500 µ/ml LM111) and 
hydrogels containing 5% PEG (0 µg/ml LM111) (p<0.003) 
c Significantly different from formulations containing 5% (0 µg/ml LM111) or 10% PEG (0 µg/ml 
LM111) (p<0.003) 
d No significant difference amongst hydrogel formulations (chi-squared, p> 0.05) 
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Figure 15. Representative images of day 28 NP cell-laden PEG-LM111 
hydrogels containing 5% PEG and 100 µg/ml LM111 (left) or 500 µg/ml LM111 (right) 
stained for cytokeratin 8, N-cadherin and integrin α3.  Scale bar = 50 µm.   
 
3.3.3 Primary NP Cell Behavior on PEG-LM111 Hydrogels in 2D 
3.3.3.1 sGAG Production 
To determine if immature NP cells form multi-cell clusters and synthesize ECM 
on PEG-LM111 hydrogel substrates, primary NP cells were seeded on PEG-LM111 
hydrogels containing 1 mg/ml LM111 and varying concentrations of PEG (2 or 10%).  NP 
cells seeded on soft, PEG-LM111 hydrogels containing low amounts of PEG synthesized 
similar levels of sGAG as compared to cells plated on laminin containing, polymerized 
BME substrates (one-way ANOVA, Tukey’s post hoc test, p>0.05) (Figure 16).  Primary 
NP cells seeded onto PEG-LM111 hydrogel substrates containing high amounts of PEG 
synthesized significantly less sGAG (Tukey’s, p<0.0001), with total sGAG production 
similar to that of cells seeded onto PEG hydrogels containing no protein.  
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3.3.3.2 Cell Morphology  
Over 4 days in culture, primary NP cells were found to form large, multi-cell 
clusters when seeded on PEG-LM111 hydrogels containing low concentrations of PEG 
(2%) or polymerized BME substrates (Figure 16).  In contrast, NP cells seeded on PEG-
LM111 substrates containing high concentrations of PEG (10%) or PEG-only substrates 
(no LM111) remained attached as single cells with uniform distribution.   
  
Figure 16. NP cell clustering and sGAG synthesis on PEG-LM111 hydrogels.  
Immature porcine NP cells were cultured on top of laminin-rich basement membrane 
extract (BME), PEG-LM111 hydrogels and PEG-only hydrogels for 4 days.  NP cells 
clustered and synthesized higher amount of sGAG on BME and PEG-LM111 
substrates containing 2% PEG and 1 mg/ml LM111 (mean ± SEM, n=5, conditions 
labeled with different letters significantly different, p<0.0001).  Scale bars = 100 µm. 
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3.4 Discussion 
The goal of this work was to develop a laminin functionalized hydrogel with 
tunable mechanical properties and to evaluate the effects of matrix stiffness and LM111 
ligand concentration on immature NP cell phenotype in vitro.  Previous work has shown 
that BME polymerized gels or soft BME upon polyacrylamide promote formation of 
multi-cell clusters for cultured primary disc cells [33, 182].  Rather than work with a 
model polyacrylamide substrate system, we engineered a biomaterial by attaching 
LM111 to PEG-based hydrogels, as PEG is non-cytotoxic, non-fouling, and has a long 
history of clinical use as a drug delivery agent for therapeutic proteins [156].  In 
addition, mechanical properties of PEG hydrogels formed by UV photopolymerization 
of PEG-DA can be easily manipulated [34].  Results reveal that specific formulations of 
the PEG-LM111 hydrogel appear to preserve features of the immature NP cell 
phenotype.  
Characterization of the bulk mechanical properties of PEG-LM111 hydrogels 
showed that PEG concentration (% w/v) was a dominant variable in determining the 
stiffness of PEG-LM111 hydrogels, with dynamic stiffness values for gels containing 10% 
PEG an order of magnitude higher than that of gels formed with 5% PEG.  PEG-LM111 
hydrogel stiffness, however, could not be completely decoupled from ligand 
concentration, as increasing the amount of PEG-LM111 conjugate also increased PEG-
LM111 hydrogel stiffness for gels containing both 5% and 10% PEG.  This finding differs 
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from that of a recent study, in which increasing the amount of LM111 conjugate in PEG-
DA hydrogels was reported to significantly decrease hydrogel stiffness [162].    Our 
finding may be related to the PEG-LM111 conjugate having an increased degree of 
modification by the addition of PEG onto LM111, thereby increasing the number of 
acrylate groups on LM1111 that can participate in the photocrosslinking reaction.  This 
feature may reduce the likelihood that a single PEGylated LM111 molecule can result in 
chain termination.  Overall, these findings demonstrate that PEG-LM111 hydrogel 
mechanical properties can be tuned within the range of dynamic shear moduli values 
previously reported for human NP [183] by altering both the total PEG concentration and 
PEG-LM111 conjugate concentration, with hydrogel stiffness being dominated by the 
former.   
For primary NP cells cultured within 3D PEG-LM111 hydrogels of varying 
stiffnesses and LM111 ligand concentration, media metabolite concentrations suggest that 
LM111 ligand density, but not stiffness of the material, has a significant effect on NP cell 
metabolism, particularly lactate production.  NP cells rely on diffusion of nutrients such 
as oxygen and glucose from the cartilaginous end plates; most of their energy is formed 
by the conversion of glucose to lactic acid; however, NP cells do require oxygen to 
function [184-186].  Interestingly, despite increased lactate production and pyruvate 
consumption by cells cultured in PEG-LM111 gels containing low concentrations of 
LM111, glucose consumption by NP cells remained low across all hydrogel formulation.  
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It is important to note that hydrogels were cultured under normoxic conditions, which 
may have led to increased oxygen consumption and reduced glycolysis by entrapped 
cells.  Increased lactate concentrations in scaffold-chondrocyte cultures at early time 
points has been shown to be a strong predictor of glycosaminoglycan and hydroxyproline 
accumulation in chondrocytes [187], suggesting that low levels of LM111 may improve 
matrix production in PEG scaffolds.   
Although it has been hypothesized that promoting or maintaining a notochordal-
like immature NP cell phenotype may be important for tissue engineering strategies 
aimed at NP regeneration, there has been limited assessment of the effects of scaffold 
design on cell phenotype.  This is in part due to the lack of specific markers that 
distinguish immature, notochordal-like NP cells from small, more chondrocyte-like NP 
cells, as well as from articular chondrocytes and AF cells.  Recently, numerous studies 
have focused on markers uniquely expressed in the immature or non-degenerate NP, and 
suggest integrin α3 [30], integrin α6 [30, 84], N-cadherin [85, 88], and cytokeratin 8 [85, 90] 
as potential NP phenotypic markers.  Here, N-cadherin was found to be highly expressed 
when immature NP cells were cultured in soft, PEG-LM111 hydrogels containing 5% PEG 
and high concentrations of LM111 (500 µg/ml), characteristic of a soft hydrogel with high 
LM111 ligand density.  Cytokeratin 8 is known to be highly expressed in the human 
notochord [74] and immature porcine NP [90], and was higher for NP cells cultured in 
PEG-LM111 gels containing 5% PEG and either low (100 µg/ml) or high (500 µg/ml) 
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amounts of LM111.  This is in contrast to the findings for PEG-LM111 hydrogels formed 
from 10% PEG or PEG-only (no LM111).  The findings for higher N-cadherin and 
cytokeratin 8 expression in LM111 containing PEG gels of 5% PEG suggests that soft, 
LM111 functionalized gels may lead to maintenance of these key features of immature NP 
cell phenotype.  NP cells were found to express varying levels of integrin α3 across 
hydrogel formulations; however, very little immunostaining for integrin α6 was observed 
for all cell-laden constructs.  This was unexpected since porcine NP cells have previously 
been shown to attach to LM111 via integrin α6 [31], while adult human NP cells make use 
of α3, α5, and β1 subunits to attach to LM111 [29].  Integrin α3 has been shown to be 
expressed in the immature human and porcine NP, but not in the adjacent AF [30], and to 
play a function role in human NP cell adhesion to laminins [29].   In this study, integrin 
α3 expression was highest for primary NP cells cultured in PEG-LM111 hydrogels that 
contained 5% PEG and either 100 or 500 µg/ml LM111; however, moderate expression was 
observed for cells cultured in the stiffer gels containing similar amounts of LM111.  This 
finding may reflect that NP cell-LM111 interactions are mediated at least in part by the 
integrin α3 subunit when attaching to the modified PEG-LM111 conjugate.   Taken 
together, immunostaining of NP cell-laden PEG-LM111 hydrogels suggest that soft, 
LM111 functionalized hydrogels may promote both cell-cell and cell-matrix interactions 
characteristic of an immature NP cell phenotype.   
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In addition to expression of specific phenotypic markers, immature NP are 
differentiated from other cells in the disc by their distinct morphology,  appearing as large, 
highly vacuolated cells arranged in multi-cell clusters.  In a prior study, immature NP 
cells seeded onto polymerized BME substrates formed large, multi-cell clusters and 
synthesized high levels of sGAG as compared to other ECM protein coated 2D rigid 
substrates [33].  In the present study, immature primary NP behavior on softer, PEG-
LM111 substrates was found to correlate closely to that of NP cells seeded onto BME gels.  
Cells seeded onto softer, PEG-LM111 hydrogels with low levels of PEG and high 
concentrations of LM111 were found to cluster and to synthesize higher levels of sGAG, 
as compared to cells seeded onto blank PEG-only or stiffer, PEG-LM111 hydrogels.  
Overall, this finding suggests that specific formulations of the PEG-LM111 hydrogel are 
able to mimic physical and biochemical properties of polymerized BME previously shown 
to promote an immature NP cell phenotype.   
 
3.5 Conclusion  
We report here on the development and characterization of a photocrosslinkable 
LM111 functionalized hydrogel with tunable mechanical properties for evaluating the 
effects of matrix stiffness and LM111 concentration on NP cell behaviors in both 2D and 
3D.  In 2D, the softer, LM111 presenting hydrogels were found to promote primary NP 
cell clustering and increased levels of sGAG production as compared to stiffer LM111 
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presenting and PEG-only gels.  In 3D, hydrogel formulation was found to influence NP 
cell metabolism and expression of proposed phenotypic markers, with higher expression 
of N-cadherin and cytokeratin 8 observed for cells cultured in softer (<1 kPa), LM111 
functionalized PEG hydrogels.  Overall, these findings suggest that softer, LM111 
functionalized scaffolds may promote or maintain an immature NP cell phenotype, and 
that incorporation of the LM111 ligand into scaffolds might be useful for studies aimed at 
NP regeneration.   
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4. Injectable PEG-LM111 Hydrogel for Nucleus Pulposus 
Regeneration  
Reproduced in part from:  Francisco AT, Mancino RJ, Bowles RD, Brunger JM, Tainter 
DM, Chen Y, Richardson WM, Guilak F, Setton LA. (2013)  Injectable laminin-
functionalized hydrogel for nucleus pulposus regeneration.  Biomaterials, 34:7381-7388.   
 
4.1 Introduction 
Cell transplantation to the IVD has been performed clinically, and aims to 
repopulate the disc with cells capable of synthesizing new ECM to restore function to the 
diseased IVD.  In animal models of IVD regeneration, implantation of autologous disc 
cells or stem cells has been shown to delay degeneration, as measured by histological and 
radiographic changes [22, 111, 130-132, 179, 188].  Although the need for a biomaterial 
carrier to improve cell retention immediately after delivery has been demonstrated [136], 
few studies have evaluated the role of the carrier in long-term cell survival and retention 
[188].  Injectable materials for cell delivery to the IVD have received considerable attention 
since they provide a minimally invasive tissue engineering approach for enhancing IVD 
regeneration.  Numerous hydrogels derived from natural components of the ECM, 
including fibrin [123, 136, 137], hyaluronan [111, 114, 189], and collagen [109, 119, 132], 
and natural biopolymers such as chitosan [116, 118, 190] have been investigated as carriers 
for cell delivery to the disc.  The development of injectable biomaterials that support cell 
retention, cell survival and maintain or promote an NP cell phenotype in vivo remains a 
significant challenge.   
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PEG hydrogels have been widely used in tissue engineering applications since 
they are biocompatible, hydrophilic polymers that readily allow for incorporation of 
biological signals derived from the native ECM [128].  Therefore, full length ECM-derived 
proteins, including collagen, fibrinogen and laminin, have been covalently coupled to 
PEG hydrogels for a variety of tissue engineering applications and shown to influence cell 
behavior in three dimensions [34, 162, 168, 169].   The majority of these studies rely on 
photocrosslinking of acrylate functional groups on PEGylated proteins and PEG-
multiacrylates to form three-dimensional hydrogels; however, conjugate addition 
between free thiols and PEG-acrylate or PEG-vinylsulfone allows gelation to occur in situ 
under physiological conditions [191, 192] without the need for UV light.  This chemistry 
enables a utility of the PEG-crosslinking hydrogel that is more suitable for the delivery of 
cells in vivo.         
The objective of this work was to develop an injectable laminin functionalized PEG 
hydrogel with tunable mechanical properties, and to assess its potential use as a carrier 
for cell-based IVD regeneration.  We describe here the synthesis and characterization of 
an injectable PEG-LM111 hydrogel via the addition of PEG-dithiol and PEG-octoacrylate 
to the PEG-LM111 conjugate developed in Chapter 2.  Additionally, we describe the 
generation of luciferase expressing primary NP cells, and the delivery of these cells to the 
disc space within our injectable biomaterial carrier. 
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4.2 Materials & Methods  
4.2.1 Injectable PEG-LM111 Hydrogel Synthesis and Mechanical 
Properties 
Preliminary studies were performed to determine if a fiber optic cable could be 
utilized to promote gelation of photocrosslinkable PEG-LM111 hydrogel precursor 
solutions in the IVD space (Appendix B).  Although gelation in situ could be achieved in 
a model disc, significant technical challenges arose during pilot in vivo studies.  Therefore, 
a modified PEG-LM111 hydrogel crosslinked via a Michael-type addition reaction was 
developed to allow for gelation in situ without the need for UV light.  PEG-octoacrylate 
(20kDa, Creative PEGworks) and PEG-dithiol (3.4kDa, Creative PEGworks) were 
dissolved separately in PEG-LM111 conjugate (25:1 Ac-PEG-NHS to LM111) solutions 
and PBS to final concentrations of 10% (w/v) PEG and 0, 100, or 500 µg/mL PEG-LM111 
conjugate (25:1 Ac-PEG-NHS to LM111). All samples were tested in oscillatory shear 
under physiological conditions (37°C, pH 7.4) in a humidified atmosphere.  Briefly, 
appropriate volumes of PEG-octoacrylate and PEG-dithiol solutions that had been 
dissolved in PEG-LM111 conjugate solution were mixed to obtain a PEG-LM111 precursor 
solution containing a 1:1 ratio of acrylate to thiol groups.  Solutions were mixed and 
immediately pipetted onto the center of a test platen (25mm diameter) within the test 
chamber of a controlled stress rheometer (AR-G2, TA Instruments, New Castle, DE).  The 
upper platen was lowered to a gap thickness of 1mm and oscillatory shear was applied 
(ω=0.5Hz, γ0=0.05). The evolution of storage (G’) and loss (G’’) moduli were recorded over 
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time, and used to calculate the complex shear modulus (|G*|).  Gelation time was 
determined by the crossover of G’ and G’’ for each hydrogel formulation.    Differences in 
gelation time and steady-state complex shear modulus amongst gel formulations were 
detected by ANOVA with Tukey’s post hoc test (p<0.05, n=5 per formulation).   
 
4.2.2 Cell Isolation and Culture  
Cells isolated from the porcine NP have a unique notochordal phenotype, and 
were therefore used to evaluate both PEG-LM111 conjugate bioactivity and for in vitro 
and in vivo cell delivery experiments.  Lumbar spines were obtained from pigs shortly 
after sacrifice (L1–L5, 4-7 months, Nahunta Pork Outlet, Raleigh NC).  Cells were isolated 
from the NP regions of IVDs by enzymatic digestion [171] and cultured in monolayer for 
3 – 7 days in culture media (Ham’s F-12 media supplemented with 10% fetal bovine serum 
(FBS), 10 mM HEPES, 100 U/ml penicillin, and 100 U/ml streptomycin) prior to 
experiments.   
 
4.2.3 Generation of Luciferase Expressing Primary NP Cells  
To generate transduction media, VSV-G pseudotyped lentivirus driving 
constitutive expression of the luciferase2 transgene (obtained from pGL4.50; Promega, 
Madison, WI) under control of the EF1α promoter (LVE-LUC2) was prepared in 293T cells 
using the standard calcium phosphate precipitation technique [193] and stored at -80°C 
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until further use. LVE-LUC2 was thawed and supernatant was centrifuged through a 100 
kDa MWCO filter (EMD Millipore, Billerica, MA).  Preliminary studies were performed 
to determine optimal LVE-LUC2 vector concentration in the transduction media that 
would promote long-term, stable luciferase expression in primary NP cells (see Appendix 
C).   A concentrated LVE-LUC2 vector (80x concentration) was mixed with NP culture 
media (5 µl concentrated virus per ml media) supplemented with 4 µg/ml polybrene® 
(Sigma-Aldrich, St. Louis, MO).  Primary porcine NP cells were isolated as described 
above, plated at a density of 40,000 cells/cm2 in culture media, and cells were allowed to 
adhere for 24 hours.  Culture media was then aspirated from NP cells and replaced with 
transduction media.  After 24 hours, LVE-LUC2 containing media was aspirated and fresh 
culture media was added.  Luciferase expressing porcine NP (NP-luc) cells were cultured 
in monolayer with media changes every 2-3 days.   To evaluate luciferase expression in 
cultured cells, bioluminescent imaging was performed using an IVIS© Kinetic, and signal 
intensities were quantified with Living Imaging software (PerkinElmer, Waltham, MA).  
NP-luc and control naïve NP cells were lifted at multiple time points post transduction 
(day 4 to 35), counted and suspended in culture media. These cells were added to separate 
wells of a 96 well black bottom tissue culture plate (5000 cells/well).  Wells were 
supplemented with 150 µg/ml D-luciferin (PerkinElmer) and imaged 10 minutes after 
addition of D-luciferin (5 sec exposure time).  Total photons per second per cell was 
calculated from the total photons in a defined circular region of interest (ROI) drawn over 
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each well.  An ANOVA was performed to analyze light emission (photons/sec/cell), using 
Tukey’s post hoc test (p<0.05, n=3) to detect differences between time points.   
 
4.2.4 Cell Retention in IVD Motion Segments 
The effect of PEG-LM111 biomaterial on cell retention and survival in the IVD was 
evaluated in an organ culture model.  Rat tails (n=8 Sprague Dawley, 200 – 250g, Charles 
River, Wilmington, MA) were harvested within 3 hours of sacrifice, skin and tendons were 
removed, and 7-8 IVD motion segments were obtained from each animal (C1-C8).  Disc 
motion segments were washed three times, and placed in sterile petri dishes.  A 
nucleotomy was performed by injecting air into the disc space via a 27G needle.  PEG-
LM111 precursor solution (10% PEG containing 1:1 acrylate to thiol ratio, 500 µg/ml PEG-
LM111 conjugate synthesized with 25:1 Ac-PEG-NHS to LM111) was prepared as 
described above.  NP-luc cells that had been cultured in monolayer for at least 10 days 
were lifted and resuspended at a concentration of 106 cells/ml in PEG-LM111 precursor 
solution or PBS, and 10 µl was delivered to the NP of individual caudal motion segments 
through a 27G needle.  The needle was held in place for 1 minute following cell delivery 
to reduce leakage.  Individual motion segments were separated, placed in separate wells 
of a 12-well plate, and overlaid with media.  Motion segments receiving no additional 
injection [194] and PEG-LM111 precursor solution only were used as negative controls. 
All motion segments were cultured out to 14 days at 37°C, 5% CO2 and 20% O2 in culture 
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media (F12 supplemented with 20% FBS, 100 U/ml penicillin, and 100 U/ml streptomycin) 
with media changes every day.  Cell retention in rat motion segments was evaluated at 
multiple time points after injection of NP-luc cells using bioluminescence imaging.  To 
evaluate cell retention in IVD motion segments, wells containing rat IVD motion segments 
were supplemented with 300 µg/ml D-luciferin and light emission was measured 2 
minutes later (30 sec exposure time).  An oval ROI was drawn around the entire motion 
segment based on a photographic image.  Total photons within each ROI was obtained 
from the overlay luminescent image.  Differences amongst cell delivery vehicles and time 
post injection were analyzed via two-factor ANOVA with Tukey’s post hoc test (p<0.05, 
n=6). 
 
4.2.5 Cell Transfer to IVD Motion Segments 
4.2.5.1 Bioluminescent Imaging  
To assess the effect of the PEG-LM111 biomaterial on initial cell transfer IVD 
motion segments, the experiment described in Section 4.2.4 was repeated, and cell 
retention was evaluated by bioluminescence imaging in the 30 minutes immediately 
following cell delivery.  Rat tail IVD motion segments and PEG-LM111 hydrogel 
precursor solutions were prepared as described in Section 4.2.4.  A nucleotomy was 
performed by air injection into the disc space (C2 – C4), and 1 x 106 cells were delivered to 
each IVD motion segment as described here: NP-luc cells were lifted and resuspended at 
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a concentration of 106 cells/ml in PEG-LM111 precursor solution or PBS, and 10 µl was 
delivered to the NP of individual caudal motion segments through a 27G needle. The 
needle was held in place for approximately 1 minute following injection.  IVD motion 
segments (n=3 per group) were immediately transferred to 12-well plates and 1 ml of 
media was added to each well.  Wells were supplemented with Luciferin-D (300 µg/ml) 
and light emission was measured immediately, and then at 2 minute intervals for 28 
minutes (30 second exposure).  An oval ROI was drawn around the entire motion segment 
based on a photographic image.  Total photons within each ROI was obtained from the 
overlay luminescent image and normalized to the total number of photons in IVD motion 
segments receiving cells in PEG-LM111 hydrogel precursor solution at time 0.  Differences 
amongst cell delivery vehicles and time post injection were analyzed via two-factor 
ANOVA with Tukey’s post hoc test (p<0.05, n=3). 
 
4.2.5.2 IVD Motion Segment Immunostaining  
To evaluate PEG-LM111 biomaterial transfer to the disc space  in an organ culture 
model,  IVD motion segments were immunostained for LM111.  At 30 minutes post cell 
delivery in either PBS or PEG-LM111 hydrogel precursor solution (n=3 per group), IVD 
motion segments were fixed in 10% neutral buffered formalin for 48 hours at 4°C, 
decalcified in Cal-Ex (Fisher Scientific) for 14 days at 4°C, processed in a series of 
increasing ethanol concentrations, and embedded in paraffin.  Eight-micrometer thick 
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sagittal sections were obtained for immunostaining.   Sections (3 sections per motion 
segment spaced approximately 800 µm apart) were deparaffinized and rehydrated in PBS, 
followed by antigen retrieval with proteinase K (Sigma).  Sections were incubated with 
blocking solution (PBS/0.05%  Tween-20 and 3.75% BSA for 10 minutes followed by 
PBS/0.05% Tween-20 and 5% Donkey Serum for 30 minutes at room temperature), 
followed by a primary antibody for LM111 (L9393, Sigma) for 2 hours at room 
temperature.  Sections were washed twice with PBS and incubated with secondary 
antibody (AlexaFluor 488, Molecular Probes, Eugene, OR) for 30 minutes in blocking 
solution.  Sections were incubated with secondary antibody only as negative controls.  
Samples were imaged via confocal microscopy (Zeiss LSM510, 10x magnification). 
 
4.2.6 Cell Delivery to Rat Tail IVD 
In vivo studies of cell persistence within the rat IVD were performed to test proof-
of-concept for use of the PEG-LM111 hydrogel as a carrier for NP-luc cells.  NP-luc cells 
were delivered to the rat tail IVD either in PEG-LM111 hydrogel, PEG-only hydrogel (no 
PEG-LM111 conjugate) or PBS.  Rats (Sprague Dawley, 200 – 250g, Charles River) were 
anesthetized with isoflurane, and a 3 cm incision was made on the dorsal side of the tail 
to obtain access to the C3-C4, C4-C5 and C5-C6 disc space.   A nucleotomy was performed 
at the C3-C4 and C5-C6 levels of each tail using a 25G needle, and the anulus fibrosus was 
closed with one 5-0 Vicryl® suture (Ethicon Inc., Somerville, NJ).  Cells in PBS, cells in 
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PEG-LM111 (PEG-octoacrylate and PEG-dithiol, 500 µg/ml PEG-LM111 conjugate), and 
cells in PEG-only (PEG-octoacrylate and PEG-dithiol, no PEG-LM111 conjugate) were 
prepared as described above.   Using a Hamilton syringe with a 27G needle, 10 µl of cells 
in PEG-LM111, cells in PBS, or cells in PEG-only was injected into the middle of the C3-
C4 or C5-C6 denucleated disc space (n=3 per group).  Disc spaces (C3-C4 or C5-C6) 
receiving either PEG-LM111 biomaterial only (10 µl) or nucleotomy only served as 
negative controls.  Skin was closed in an interrupted manner using 4.0 nylon sutures.  For 
in vivo bioluminescent imaging, D-luciferin (150 mg/kg) was injected intraperitoneally 15 
min before imaging, after which rats were anesthetized with 1-3% isoflurane and imaged 
(5 min exposure time).  For ex vivo bioluminescent imaging, rat tails were harvested 
immediately after sacrifice, skin and tendons were removed, and IVD motion segments 
(C2-C6) were obtained from each animal.  Disc motion segments were placed in sterile 
petri dishes, overlaid with culture media, and supplemented with 300 µg/ml D-luciferin.  
Light emission was measured 2 minutes later (300 sec exposure time).  All procedures 
were approved by the IACUC and were performed in accordance with Duke University 
guidelines. 
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4.3 Results  
4.3.1 Injectable PEG-LM111 Hydrogel Mechanical Properties 
When PEG-LM111 conjugate solution or PBS was mixed with PEG-octoacrylate 
and PEG-dithiol under physiological conditions (37°C, pH 7.4), hydrogels formed in less 
than 25 minutes by the reaction of thiols and acrylates, as measured by the point of 
crossover of G’ and G’’ (Figure 17A).  For hydrogels containing 500 µg/ml PEG-LM111 
conjugate, the gel point occurred in less than 14 minutes.  PEG-only (no PEG-LM111 
conjugate) and PEG-LM111 hydrogel mechanical properties continued to evolve for 
approximately 1 hour.  The final gel stiffness (|G*|) increased with increasing 
concentrations of PEG-LM111 conjugate in the precursor solution (Figure 17B). 
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Figure 17. Rheometric characterization of injectable PEG-LM111 hydrogels. (A) 
Gel point occurred in less than 25 minutes for hydrogels containing different 
concentrations of PEG-LM111 conjugate (mean ± SEM, n=5, conditions labeled with 
different letters significantly different, p<0.04).  (B) Final gel stiffness (|G*|) of PEG-
LM111 hydrogels increased with increasing concentration of PEG-LM111 conjugate in 
the precursor solution.   
 
4.3.2 Generation of Luciferase Expressing Porcine NP Cells 
To track cells following delivery to the IVD using in vivo bioluminescent imaging, 
it was necessary to verify that NP-luc cells maintain luciferase expression for at least 4 
weeks post transduction.   Luciferase expression in NP-luc cells cultured in monolayer 
increased approximately 3.5-fold from day 4 to day 35 post transduction; however, there 
was no significant difference in expression between day 24 and day 35  (ANOVA, p>0.05) 
(Figure 18).   
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Figure 18. Luciferase activity in cultured porcine NP cells.  NP cells transduced 
with lentivirus encoding for firefly luciferase were cultured for 35 days post 
transduction.  At each time point, photons per second per cell was calculated from 
measured bioluminescent intensity 10 minutes after addition of luciferin to the media 
(mean ± SEM, n=3, conditions labeled with different letters significantly different, 
p<0.03).   
 
4.3.3 Cell Retention in IVD Motion Segments 
Bioluminescence imaging was utilized to examine the effect of PEG-LM111 
hydrogel carrier on NP-luc cell retention and survival in IVD motion segments.  The total 
number of photons in a defined region of interest (ROI) was quantified at multiple time 
points following cell injection (Figure 19B).  Cell retention in IVD explants was 
significantly higher (ANOVA, p<0.001) over 14 days in culture when cells were delivered 
within a PEG-LM111 hydrogel carrier, as compared to cells in PBS (Figure 19A).  At 30 
minutes post injection, bioluminescent signal was 13-fold higher when cells were 
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delivered to IVDs in PEG-LM111 biomaterial; however, signal rapidly decayed over the 
first 24 hours of culture for both groups.  NP-luc cells in IVD explants could be detected 
via bioluminescent imaging for at least 14 days post injection.  
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Figure 19. Cell retention in IVD motion segments.  (A) NP-luc cells were 
delivered to rat IVD motion segments and explants were cultured for 14 days.  Cell 
retention, as measured by total photons per motion segment, was higher for cells 
delivered in PEG-LM111 hydrogel precursor solution as compared to cells delivered 
in PBS (mean ± SEM, n=6, conditions labeled with different letters significantly 
different, p<0.001).  (B) Region of interest (ROI) defined on photographic image of 
motion segment used quantify total photons per motion segment in overlay image.  
(C) Representative images of IVD motion segments 30 minutes and 7 days post cell 
injection within PEG-LM111 biomaterial hydrogel precursor solution or PBS.   
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4.3.4 Cell Transfer to IVD Motion Segments  
To determine whether an optimized PEG-LM111 hydrogel improved cell transfer 
to the disc space, cell retention immediately following delivery, or both, IVD motion 
segments that received NP-luc cells delivered in either PBS or PEG-LM111 hydrogel 
precursor solution were imaged immediately following cell delivery, and every 2 minutes 
for 28 minutes after delivery (Figure 20).   At time 0, bioluminescent signal was the same 
for cells delivered in PBS and cells delivered in PEG-LM111 hydrogel precursor solution.  
For both groups, signal decayed over the first 28 minutes following delivery; however, 
total photons per motion segments decreased more rapidly when cells were delivered in 
PBS as compared to cells delivered in PEG-LM111 hydrogel precursor solution.    
To evaluate PEG-LM111 hydrogel solution transfer to the IVD space, cells were 
delivered to IVD motion segments within either PBS or the PEG-LM111 hydrogel 
precursor solution and, 30 minutes after delivery, explants were fixed and processed for 
immunohistochemical analysis.  Immunostaining for LM111 revealed that the PEG-
LM111 hydrogel could be detected in the disc space, with positive staining observed when 
cells were delivered in PEG-LM111 hydrogel precursor solution, but not when cells were 
delivered in PBS (Figure 21).   
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Figure 20.  Cell transfer to IVD motion segments.  (A) NP-luc cells were 
delivered to rat IVD motion segments and cell transfer and retention were evaluated 
via bioluminescent imaging in the 30 minutes immediately following cell delivery.  
(A)  Representative images of IVD motion segments 0, 2, 8, 16, and 28 minutes after 
NP-luc cells were injected within PBS or PEG-LM111 hydrogel precursor solution.  (B) 
The number of cells delivered to IVD motion segments, as measured by total photons 
per motion segment, was the same for cells delivered in PEG-LM111 hydrogel 
precursor solution and PBS at time 0.  Cell retention over 30 minutes post injection 
was higher for cells delivered in PEG-LM111 hydrogel precursor solution as 
compared to cells delivered in PBS (mean ± SEM, n=3, conditions labeled with 
different letters significantly different, p<0.001).   
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Figure 21. Representative images of IVD motion segments 30 minutes after 
cells were delivered either in PBS (left) or PEG-LM111 hydrogel precursor solution 
(right) that were stained for LM111 (green: LM111; red: nuclei).  Scale bar = 100 µm.   
 
4.3.5 In Vivo Cell Delivery to Rat IVD  
 Preliminary studies were performed to determine if NP-luc cells, delivered to the 
rat tail IVD in PBS, PEG-LM111 hydrogel precursor solution, or PEG-only hydrogel 
precursor solution, could be detected via in vivo bioluminescent imaging.  Cells could be 
detected in vivo up to 7 days following injection into the IVD space (Figure 22); however, 
bioluminescent signal was low, variable, and no signal was observed at multiple time 
points whether cells were delivered in PEG-LM111 hydrogel precursor solution, PEG-
only hydrogel precursor solution or PBS.  Due to these limitations, and the small sample 
size of this study, differences between luminescent signal intensities amongst cell carrier 
(PBS or PEG hydrogel precursor solutions) were not analyzed.   In certain animals, cells 
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could not be detected in vivo, but could be detected in the IVD space ex vivo immediately 
following sacrifice (Figure 23).  For all animals at all in vivo imaging time points, 
maximum luminescent signal did not exceed 3500 counts over a 5 minute exposure time, 
possibly due to a low number of delivered cells, low luciferase expression levels, poor 
luciferin distribution to the tail, and signal attenuation by the collagenous tail skin. 
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Figure 22. In vivo bioluminescent imaging at several time points after NP-luc 
cells were injected into the rat tail disc space, and ex vivo imaging of IVD motion 
segments immediately after animal sacrifice on day 14.  Arrows indicate IVDs to 
which cells were delivered either in a PEG hydrogel precursor solution or PBS.   
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Figure 23. In vivo and ex vivo bioluminescent imaging of rat tail IVDs at 
specific time points after cells were delivered to the disc in either PBS (top row) or in 
a PEG hydrogel precursor solution (bottom row).  Arrows indicate disc spaces 
receiving injection of cells either in PBS (top) or in a PEG hydrogel precursor solution 
(bottom).     
 
4.4 Discussion 
The goal of this work was to develop an injectable, laminin-functionalized 
hydrogel as a biomaterial carrier for cell delivery to the IVD.  Laminin presenting 
substrates have previously been shown to promote the morphology and phenotype of 
immature NP cells in vitro, and to promote increased cell attachment and elevated 
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glycosaminoglycan synthesis for primary NP cells in culture [33, 95].  For these reasons, a 
3D biomaterial carrier presenting laminin was developed as a carrier for primary NP cells.   
PEG-LM111 conjugates were crosslinked to form hydrogels upon the addition of 
PEG-octoacrylate and PEG-dithiol via a Michael type addition reaction without the need 
for an initiator, as has been shown for PEG hydrogels designed for protein delivery [191].  
Gelation occurred within 20 minutes under physiological conditions independent of the 
concentration of PEG-LM111 conjugate in the precursor solution.  The reaction was thus 
considered to provide for an acceptable working time for cell delivery in vivo since it 
allows time for cell suspension and accurate needle placement within the disc space [195].  
The dynamic stiffness of PEG-LM111 hydrogels in shear increased slightly from ~0.9 kPa 
to ~1.5 kPa with increasing concentration of PEG-LM111 conjugate in the precursor 
solutions, all values that are only slightly lower than values reported previously for the 
dynamic shear moduli of human NP (7.4 – 19.8 kPa) [181, 183]. Stiffness can be readily 
manipulated to achieve a targeted goal by modifying the amount of PEG within the 
crosslinked hydrogel.  In a prior report of PEG-laminin hydrogels crosslinked by 
photopolymerization, hydrogel stiffness decreased with increasing concentration of the 
PEG-laminin conjugate precursor solutions [162], a finding that differs from that observed 
in the current study.  This difference likely reflects intrinsic differences between step-
growth and chain-growth polymerization reactions in the two different systems; our 
finding suggests that high concentrations of PEG-LM111 conjugate in the precursor 
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solution reduces the number of non-idealities in the crosslinked hydrogel network, which 
are introduced in hydrogels formed by Michael-type addition reactions at low PEG 
concentrations [196].  This is a feature that can be modulated to achieve a targeted 
outcome through biomaterial design if it should become desirable to modulate the 
porosity or stiffness, for example, to achieve a specific set of biological outcomes [197].  
Here our goal was to obtain a material that retained laminin functionality, provided good 
working characteristics, and physical properties that approximated that of the native NP.  
Overall, these findings suggest this laminin-functionalized biomaterial can provide an 
injectable carrier for delivering cells to the IVD. 
To evaluate cell retention within the disc space following delivery, much of the 
work using animal models of disc degeneration has relied on histological techniques 
subsequent to animal sacrifice at specific time points, which precludes in vivo assessment 
and longitudinal tracking of cell therapy.  Bioluminescence imaging may be a useful tool 
for evaluating the efficacy of a biomaterial carrier for cell delivery; however, long-term 
stable expression of luciferase in delivered cells must be achieved in order to evaluate cell 
retention and survival in the disc space.    Towards the goal of in situ and in vivo 
assessment of the effect of our PEG-LM111 biomaterial carrier on NP cell retention and 
survival in the disc space, we demonstrate here sustained expression  of the luciferase 
reporter gene in immature primary NP cells over 5 weeks in culture.  This is a significant 
improvement over a transient luciferase expression reported in rabbit NP cells transfected 
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with a recombinant adenovirus, which allowed for follow-up of cell viability for only 
about 6 days [136].  Although sustained luciferase expression in NP cells was achieved, 
expression levels did vary significantly over time, preventing the use of bioluminescent 
signal intensity to directly quantify number of cells in cell tracking studies.  
Many biomaterials have been investigated as carriers for cell delivery to the IVD 
in numerous animal models of disc degeneration [22].  While solid scaffolds are widely 
used to support IVD cell growth ex vivo [19, 100, 198], we have focused in this study on 
injectable, in situ polymerizing three-dimensional hydrogels that could maintain the 
rounded phenotype for NP cells.  Naturally derived biopolymers and self-polymerizing 
biomaterials such as collagen, chitosan and fibrin are most commonly utilized for NP 
regeneration, although the physical properties and chemical composition of these 
biomaterials is not easily manipulated [26].    Chemical crosslinking of alginate is the most 
commonly used approach to promote a rounded phenotype for NP cells and is the 
standard for cell culture studies [105].  More recently, photocrosslinking of alginate has 
been proposed as a means to manipulate a three-dimensional matrix for NP cells [199], 
and a self-assembling peptide hydrogel has been similarly investigated [200].  Few 
injectable biomaterials have presented functional ECM ligands that can retain native NP 
cell-matrix interactions and facilitate cell-mediated matrix remodeling, which may be 
important for promoting long-term cell survival and biosynthesis.   
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While prior studies have established the importance of a biomaterial carrier for 
improved cell transfer to the disc space immediately following delivery [136], little is 
known of the role of the biomaterial carrier in promoting long-term cell retention and 
survival [188].  Studies were performed here to test for an ability of the newly synthesized 
PEG-LM111 biomaterial to promote NP cell retention and survival in the disc space, by 
following luciferase expression for immature primary NP cells delivered via needle 
injection to the disc space in an organ culture model.   The optimized PEG-LM111 
hydrogel significantly improved primary NP cell retention and survival as compared to 
cells delivered in an uncrosslinked, liquid suspension.  Thirty minutes after injection, 
bioluminescent signal was 13-fold higher when cells were delivered in a PEG-LM111 
biomaterial, suggesting that cell delivery in the absence of a solid-setting carrier may 
result in dramatic cell loss [136].  These findings suggest that an optimized PEG-LM111 
hydrogel is able to crosslink in situ and significantly improve upon the retention of 
delivered cells.  The PEG-LM111 hydrogel was unable to inhibit complete cell loss, 
however, as cells continued to die or migrate from the disc space over the first 24 hours 
after delivery, likely due to a high intra-discal pressure that induced extrusion through 
the injection site.  This highlights the need for annular repair techniques in addition to 
biomaterials for cell delivery, or high-strength crosslinked biomaterial carriers, that may 
need to be employed to slow or eliminate cell loss following delivery [201].  
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In a prior study, significantly higher bioluminescent signal was shown when cells 
were delivered to IVD explants within a fibrin gel carrier, as compared to cells in media, 
at 30 minutes after delivery [136].   Similar findings were reported here for cells delivered 
within a PEG-LM111 hydrogel precursor solution compared to cells delivered in PBS; 
however, these studies did not evaluate whether the difference in bioluminescent signal 
at this early time point is due to improved initial cell transfer, improved cell retention due 
to gel crosslinking, or both.  Here, short-term bioluminescent imaging studies were 
performed to evaluate cell retention in IVD motion segments immediately following 
delivery.  At time 0, total photons emitted from IVD motions segments were the same 
whether cells were delivered with or without a PEG-LM111 hydrogel precursor solution, 
suggesting an equivalent number of viable cells were initially delivered to each disc 
regardless of carrier.  Although bioluminescent signal decreased for both groups over the 
first 30 minutes following delivery, total photons per motion segments was significantly 
higher when cells were delivered in the PEG-LM111 hydrogel precursor solution.  These 
findings provide further evidence that this injectable, PEG-LM111 hydrogel improves 
retention of delivered cells, at least at early time points, by preventing leakage from the 
disc space.     
In addition to evaluating cell retention in IVD motion segments, it is of interest to 
evaluate material distribution in the disc space.  When cells were delivered to motion 
segments within a PEG-LM111 hydrogel, the material was detected within in the disc 
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space 30 minutes after delivery by positive staining for LM111.  Staining was isolated to a 
small region of the NP, suggesting that material either is not able to distribute throughout 
the disc space, possibly due to incomplete nucleotomy, not distributed uniformly before 
crosslinking, or that the material is quickly extruded from the disc space due to a high 
intra-discal pressure.  Similar findings were reported for cells delivered to minipig lumbar 
IVDs within a fibrin carrier supplemented with aluminum oxide particles for evaluation 
of material retention by micro-computed-tomography [137].  Although the fibrin carrier 
appeared distributed throughout the disc on day 0, over 90% of the material and 93% of 
the cells were lost by day 3 [137].   Overall, these findings suggest cell loss following 
delivery may be attributed to biomaterial carrier extrusion from the disc space and point 
towards an important role for AF repair.   
Cell delivery to the disc space has been performed in animal models of disc 
degeneration and in human subjects for more than a decade [22].  Cell retention within 
the disc space is difficult to follow in the living subject, particularly for clinical studies that 
rely upon minimal modification of delivered cells.  Much of the work studying cell 
delivery to the disc space in animal models has relied on histological techniques 
subsequent to animal sacrifice at specific time points, which precludes in vivo assessment 
and longitudinal tracking of cell therapy.  In a recent study, investigators demonstrated 
the feasibility of bioluminescence imaging for monitoring the viability of luciferase 
expressing cells within the lumbar spine in a rodent model up to 14 days after cell 
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implantation [202].  Here, we performed preliminary studies to determine if similar in 
vivo bioluminescent imaging could be used to track NP-luc cells delivered to the rat 
caudal IVD.  Although cells could be detected in the disc space for up to 7 days following 
delivery, bioluminescent signal intensity was extremely low even over long exposure 
times, and signal varied over time whether cells were delivered in a PEG hydrogel 
precursor solution (PEG-LM111 or PEG-only) or in PBS.  Photon emission at the tissue 
surface depends on the number of delivered cells, the photon flux per cell (luciferin 
expression levels and luciferin availability), and the signal attenuation by the tissue [203].  
Therefore, the very low bioluminescent signals that we reported from in vivo imaging are 
likely due to a combination of factors, including our delivery of comparatively low cell 
numbers to the disc space, low luciferase expression levels in delivered cells, poor 
luciferin distribution to the tail, and signal attenuation by the collagenous tail skin.  In 
some cases, cells could not be detected in vivo, but could be detected in the IVD space ex 
vivo immediately following sacrifice.  This finding suggests that either luciferin did not 
reach the caudal IVD space following intraperitoneal injection, or that signal was 
attenuated by tissue surrounding the disc space.  In a subset of animals, no signal was 
detected in discs receiving cells injected in either a PEG hydrogel precursor solution (PEG-
LM111 or PEG-only) even ex vivo at early time points.  This could be due to a failure to 
inject cells into the NP region of the disc, or rapid extrusion of cells from the IVD space.  
Overall, these findings demonstrate numerous limitations that must be overcome in order 
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to use in vivo bioluminescent imaging to evaluate the effects of a PEG-LM111 hydrogel 
on NP-luc cell retention and survival following delivery to the rat caudal IVD.   
 
4.5 Conclusion 
We report here the development and characterization of an injectable laminin 
functionalized PEG hydrogel as a biomaterial carrier for cell delivery to the IVD.  The 
findings from this study demonstrate the ability of PEG-LM111 hydrogels to crosslink 
under physiological conditions without the need for an initiator.  Additionally, delivery 
within our PEG-LM111 hydrogel significantly improved primary NP cell retention in the 
disc space as compared to cells delivered without a carrier in an organ culture model.  
Bioluminescence imaging for evaluating the effect of our carrier on persistence and 
viability of delivered cells in vivo merits further investigation.  In summary, these findings 
suggest that this laminin functionalized hydrogel may be a useful carrier for cell-based 
strategies aimed at regenerating the IVD.    
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5. Conclusion and Future Directions 
There is significant interest in cell-based therapies for treating IVD disorders, with 
the majority of these strategies focused on NP regeneration as a means to impede or 
reverse disc degeneration.   Aging associated loss of immature, notochordal-like NP cells 
has been hypothesized to be a contributing factor to IVD degeneration, and suggests that 
promoting or maintaining this distinct cell phenotype may be useful for NP tissue 
regeneration.  Immature, notochordal-like NP cells reside in an environment rich in 
laminin ECM proteins and laminin receptors, and NP cell-laminin interactions have been 
shown to promote cell adhesion and biosynthesis.  Motivated by these findings, two types 
of LM111 functionalized PEG hydrogels were synthesized and characterized, using 
photo-initiated or spontaneous crosslinking strategies for injectable hydrogel delivery.  
Immature NP cell interactions with photocrosslinked PEG-LM111 hydrogels were 
evaluated to determine hydrogel formulations that promote cell-cell interactions and 
phenotypic marker expression characteristic of notochordal-like NP cells.  Additionally, 
studies were performed to assess the potential use of an in situ crosslinking, injectable 
PEG-LM111 hydrogel as a biomaterial carrier for cell-based IVD regeneration.  Results of 
the investigations reported in this dissertation produced several key findings:  
 LM111 PEGylation via a heterobifunctional Ac-PEG-NHS at low ratios of PEG to 
LM111 (≤ 25:1) allows for the addition of functional acrylates groups onto native 
LM111 without significantly altering the protein’s ability to mediate cellular function. 
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 Immunostaining of photocrosslinked PEG-LM111 hydrogels containing conjugates 
synthesized with varying ratios of Ac-PEG-NHS to LM111 revealed that a threshold 
level of protein modification likely must be achieved in order for PEG-LM111 
conjugates to become part of the hydrogel backbone.   
 LM111 may act as a survival ligand for primary immature NP cells cultured in PEG 
hydrogels under low cell density, serum free conditions, and PEGylated LM111 
retains this biological function of the native protein in 3D culture.   
 Photocrosslinked PEG-LM111 hydrogel mechanical properties can be tuned within 
the range of dynamic shear moduli values previously reported for human NP by 
altering both the total PEG concentration and PEG-LM111 conjugate concentration; 
however, hydrogel stiffness is dominated by the former.   
 NP cells cultured within soft, photocrosslinked PEG-LM111 hydrogels more highly 
expressed proposed immature NP phenotypic markers N-cadherin and cytokeratin 8, 
suggesting that soft, LM111 functionalized hydrogels may promote both cell-cell and 
cell-matrix interactions characteristic of an immature NP cell phenotype. 
 NP cells cultured on soft, PEG-LM111 hydrogel substrates behaved similarly to cells 
cultured on polymerized basement membrane extract (BME) substrates, indicating 
that specific formulations of the photocrosslinked PEG-LM111 hydrogel are able to 
mimic physical and biochemical properties of polymerized BME previously shown to 
promote an immature NP cell phenotype.   
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 Injectable PEG-LM111 hydrogels synthesized via the addition of PEG-octoacrylate 
and PEG-dithiol to PEG-LM11 conjugates are able to crosslink under physiological 
conditions in approximately 20 minutes without the need for an initiator.   
 An optimized injectable PEG-LM111 hydrogel is able to crosslink in situ and 
significantly improve upon the retention of cells delivered to the disc as compared to 
cells delivered without a hydrogel carrier.   
 Cell extrusion from the disc space following delivery with or without a hydrogel 
carrier highlights the need for anular repair techniques in addition to biomaterials for 
cell delivery, or high-strength crosslinked biomaterial carriers in order to improve cell 
retention. 
 Bioluminescence imaging may be a useful tool for evaluating the effect of PEG-LM111 
hydrogel carrier on persistence and viability of delivered cells in vivo; however further 
investigation is necessary to overcome discussed limitations.  
The findings presented here also suggest a number of areas for future study:  
1. Studies in Chapters 2 and 3 described the development and characterization 
of PEG-LM111 hydrogels, and evaluated the effects of hydrogel stiffness and 
LM111 ligand on immature NP cell phenotype in vitro.  While LM111 is known 
to support NP cell adhesion, LM332 and LM5111 have been shown to be 
preferred ligands for NP cell attachment and spreading [95].  NP cell behavior, 
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include phenotypic marker expression and survival, in PEG hydrogels 
functionalized with these laminin isoforms remains to be investigated.  One 
major limitation that must be overcome in order to develop PEG-laminin 
hydrogels functionalized with LM332 or LM511 is ligand availability, since 
these ligands must be purified from cell supernatant or extracted from tissues.  
One possible approach would be to recombinantly express these isoforms.  
Additionally, a high throughput culture system could be developed for 
evaluating cell behaviors within PEG-laminin hydrogels, which would 
significantly reduce the amount of laminin ligand needed for each study. 
2. Studies in Chapter 3 demonstrated that soft, LM111 functionalized substrates 
promote proteoglycan synthesis by NP cells in 2D; however, proteoglycan 
production by immature NP cells encapsulated in 3D PEG-LM111 hydrogels 
remains to be thoroughly investigated.  Although the studies described here 
were aimed at evaluating the effect of hydrogel formulation on NP cell 
phenotype, assessing matrix production by NP cells cultured within PEG-
LM111 hydrogels will be key to understanding which hydrogel formulations 
(if any) promote regeneration of a proteoglycan-rich NP-like ECM.  Since cell-
cell interactions may be important for NP viability and biosynthesis, 
modifications to the current hydrogel system to include degradable linkages 
would likely result in improved NP tissue regeneration.  One possible 
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approach would be to incorporate MMP degradable linkages, since MMP 
expression is known to play an important role in degradation of the NP [204].  
Alternatively, a degradable linkage such as poly(lactic acid) could be 
incorporated into PEG-LM111 hydrogels to engineer scaffolds with tailored 
degradation behavior [205].  Studies of NP cell behavior in PEG-LM111 
hydrogels with controllable degradation properties, including cell clustering 
and matrix production, would lend further insight into the potential of LM111 
functionalized hydrogels for promoting NP tissue regeneration.   
3. Studies in Chapter 3 demonstrated higher expression of certain immature, NP 
markers such as N-cadherin and cytokeratin 8 for immature NP cells cultured 
in soft, PEG-LM111 hydrogels.  While these findings show that these specific 
hydrogel formulations promote certain characteristics of the immature NP cell 
phenotype, expression of only a subset of proposed NP cell markers was 
investigated.  Future studies evaluating a broader set of NP markers would be 
useful for further understanding of the effects of LM111 ligand and matrix 
stiffness on immature NP cell phenotype.    
4. Studies in Chapter 4 revealed that NP cell delivery to IVD motion segments 
within a PEG-LM111 hydrogel resulted in improved cell retention or survival 
in the disc space as compared to cells delivered in liquid suspension.   Whether 
this is due to physical gelation of the hydrogel preventing cell leakage, 
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presence of the LM111 ligand contributing to cell survival, or both, remains to 
be investigated.   Future studies of cell persistence in IVD explants following 
delivery within the PEG-LM111 hydrogel as compared to that of cells 
delivered in a PEG-only hydrogel would help elucidate the role of the LM111 
ligand in cell retention and survival.  Additionally, varying PEG-LM111 
hydrogel physical properties to reduce gelation time and increase gel stiffness 
may reduce cell leakage from the IVD space, and merits further investigation.     
5. Preliminary in vivo studies described in Chapter 4 showed that delivered NP-
luc cells could be detected within the rat tail IVD space via bioluminescent 
imaging up to 7 days following delivery.  Future work is necessary to 
determine the effects of the developed PEG-LM111 hydrogel carrier on 
primary NP cell retention, survival and matrix production in vivo.  However, 
there are several challenges that must be overcome to facilitate these studies.  
Cell delivery to the rat tail IVD creates numerous surgical challenges due its 
small size; therefore, future studies in a larger animal model would be useful 
for evaluating the potential of an injectable PEG-LM111 hydrogel as a carrier 
for cell-based regeneration of the NP.  Challenges related to bioluminescent 
imaging could potentially be overcome by increasing the number of delivered 
cells, increasing luciferase expression in transduced NP cells, or through 
alternate luciferin delivery routes to improve luciferin distribution to the disc 
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space.  While this would provide useful information cell persistence in the disc 
space, additional outcome measures of cell viability, sGAG production, and 
NP water content will be key to evaluating the potential of PEG-LM111 
hydrogels for cell-based NP regeneration.   
6. Studies described in this dissertation utilized primary porcine notochordal-
like NP cells; however, there is no available human source of notochordal-like 
NP cells for cell-based IVD regeneration.  For this reason, numerous stem cell 
sources have been investigated for their ability to differentiate towards and NP-
like cell phenotype.  Future work to evaluate induced pluripotent stem cell 
and/or mesenchymal stem cell differentiation in PEG-LM111 hydrogels will be 
important for determining if laminin-functionalized hydrogels can promote an 
NP cell phenotype in these more available cell types.   
7. Finally, while the NP region of the disc is an immunoprivileged site, it is clear 
from the studies described in Chapter 4 and those previously reported in the 
literature that biomaterial carriers can be extruded from the disc space 
following delivery. Therefore, studies must be performed to evaluate the in 
vivo immune response to injected or implanted PEG-LM111 hydrogels.  Future 
studies examining the extent of any immune reaction to PEG-LM111 hydrogels 
implanted subcutaneously in a rat model would be critical to understanding 
the usefulness of the material as a carrier for cell delivery to the disc.   
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In summary, this dissertation described the development and characterization of 
two different LM111 functionalized PEG biomaterials.  Studies examining primary NP 
cell interactions with photocrosslinkable PEG-LM111 hydrogels indicated that soft, 
LM111 functionalized hydrogels may maintain or promote a notochordal-like NP cell 
phenotype.  Since photocrosslinking can not easily be achieved in the IVD space, a 
Michael-type addition reaction was employed to synthesize and injectable PEG-LM111 
hydrogel capable of crosslinking in situ without the need for an initiator or UV light.  
Studies examining cell retention in IVD explants showed that cell delivery within an 
optimized PEG-LM111 hydrogel significantly improved primary NP cell retention in the 
disc space as compared to cells delivered without a carrier.  Overall, these findings suggest 
that this injectable laminin-functionalized biomaterial may be a convenient and 
biocompatible carrier for delivering cells to the IVD.   
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Appendix A 
Preliminary studies were performed to determine culture conditions under 
which the majority of primary porcine NP cells encapsulated in photocrosslinked PEG-
DA hydrogel (containing no LM111) would die over 14 days in culture.  Cells were 
encapsulated in PEG-DA hydrogels at two different cell densities (2 x 106 or 10 x 106 
cells/ml) as described in Section 2.2.7.  Cell laden hydrogels were cultured (37 °C, 5% 
CO2, 20% O2) for 14 days in media (Ham’s F-12 media, 10 mM HEPES, 100 U/ml 
penicillin, and 100 U/ml streptomycin) either with or without 1% FBS.  Cell viability (% 
live) was determined at multiple time points (days 0, 7 and 14) as described in Section 
2.2.7.  Less than 20% of cells cultured in PEG-DA hydrogels at 2 x 106 cells/ml under 
serum free conditions remained viable after 14 days in culture (Figure 24).   Therefore, 
these culture conditions were utilized for studies designed to assess the ability of LM111 
to promote NP cell survival in 3D culture (Chapter 2).   
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Figure 24. Cell viability in PEG-only hydrogels.  NP cell viability in PEG-
based hydrogels after 0, 7, and 14 days of culture.  Percent viability determined by 
counting the number of live cells as a percentage of total cells in images of hydrogels 
stained with Live/Dead viability assay (mean ± SD, n=3).   
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Appendix B 
 Cell delivery to the IVD within a PEG-LM1111 hydrogel carrier requires that the 
hydrogel precursor solution initially be liquid to allow for cell suspension and injection 
through a needle, and that the solution crosslink in situ following injection into the IVD 
space.  Since photocrosslinkable PEG-LM111 hydrogels require UV light to initiate 
gelation, a UV fiber coupled LED system was developed in order to promote 
crosslinking of the PEG-LM111 biomaterial in the disc space via a fiber optic cable 
threaded through the injection needle.   
Studies were performed to determine if a UV fiber coupled LED could be utilized 
to promote in situ gelation of photocrosslinkable PEG-LM111 hydrogel precursor 
solutions in a model disc space.  A UV fiber optic cable (400 µm core, 0.48 NA fiber) was 
coupled to a LED light source (High Power Fiber-Coupled LED Light Source, 365nm 
UV, Mightex Systems, Pleasanton, CA) through a standard SMA fiber adaptor port 
(Figure 25A).  A LED driver (maximum current 1000 mA, Mightex Systems, Pleasanton, 
CA) was utilized to drive the LED light source.  A model disc containing a cylindrical 
hole in a dacron mold with a side port to allow insertion of the UV fiber optic cable was 
used to evaluate crosslinking in situ.  PEG-LM111 hydrogel precursor solution (10% 
PEG-DA, 0.1% Irgacure 2959®) was prepared as described in Section 2.2.5 and 20 µl was 
loaded into the model disc space.  The fiber optic tip was then inserted through the side 
port and 350 mA power was supplied for 5 minutes (Figure 25B).   UV light exposure via 
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the fiber optic cable resulted in a completely crosslinked PEG-LM111 hydrogel that 
could be removed from the model disc space (Figure 25C).   
 
Figure 25.  In situ crosslinking of photocrosslinkable PEG-LM111 hydrogel 
precursor solutions.  (A) Setup of fiber coupled LED, driver, and fiber optic cable for 
UV crosslinking in a model disc. (B) UV irradiation of PEG-LM111 hydrogel 
precursor solution in a model disc space via a fiber optic cable. (C) Photocrosslinked 
PEG-LM111 hydrogel following crosslinking in model disc.   
 Preliminary experiments were performed to determine if the fiber optic cable 
threaded through a 22 gauge needle could be used to crosslink PEG-LM111 hydrogel 
precursor solution in a model disc space.  Only a very small volume of the PEG-LM111 
hydrogel precursor solution crosslinked in situ after 5 minute exposure to UV light (350 
mA).  This could be due to damage to the fiber optic tip causing light scattering, or due 
to the needle preventing light from reaching the hydrogel precursor solution.   
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Appendix C 
 Preliminary studies were performed to determine optimal LVE-LUC2 vector 
concentration in the transduction media that would promote long-term, stable luciferase 
expression in primary NP cells for organ culture and in vivo cell delivery studies 
(Chapter 4).  First, to determine efficiency of lentiviral transduction of primary porcine 
NP cells, NP cells were transduced with a lentivirus driving constitutive expression of 
the green fluorescent protein (GFP) transgene under control of the EF1α promoter (LVE-
GFP).  A concentrated LVE-GFP (~70x concentration) was mixed with NP culture media 
at varying concentrations (µl concentrated virus per ml media supplemented with 4 
µg/ml polybrene®) to prepare transduction media containing varying viral loads.   
Primary porcine NP cells were isolated as described in Section 4.2.2, plated at a density 
of 40,000 cells/cm2 in culture media, and cells were allowed to adhere for 24 hours.  
Culture media was then aspirated from NP cells and replaced with transduction media 
containing varying viral loads (6 - 100 µl concentrated virus per ml media).  After 24 
hours, LVE-GFP containing media was aspirated and fresh culture media was added.  
GFP expressing porcine NP (NP-GFP) cells were cultured in monolayer (37 °C, 5% CO2, 
20% O2) with media changes every 2-3 days.   NP-GFP cells and untransduced control 
cells were lifted at multiple time points, washed twice in PBS, and the mean fluorescence 
intensity and percent of GFP positive cells was measured by flow cytometry (Accuri C6, 
BD Accuri Cytometers Inc., Ann Arbor, MI).  Negative untransduced control cells were 
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used to establish a gate containing 98.5% of the GFP negative cells; the percent above 
this gate were considered positively labeled.   
 At day 3 post transduction, mean fluorescence intensity values increased with 
increasing viral load (µl concentrated LVE-GFP per ml media); however, similar 
expression levels were observed for all viral loads at later time points (Figure 26).  At 
day 3 post transduction, greater than 97% of cells were GFP positive for all viral loads 
(data not shown).   
 
Figure 26. GFP expression in primary NP cells transduced with varying viral 
loads (µl concentrated LVE-GFP per ml media).  UT = untransduced cells.  At each 
time point, cells were lifted and analyzed by flow cytometry.  
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 Since preliminary studies showed high levels of transduction and sustained GFP 
expression in primary NP cells after a single exposure to LVE-GFP containing 
supernatant, the luciferase2 transgene was cloned into the same lentiviral expression 
plasmid.  The lentivirus driving constitutive expression of the luciferase2 transgene 
under control of the EF1α promoter (LVE-LUC2) was prepared as described in Section 
4.2.3.  Preliminary studies using this vector were performed to determine optimal LVE-
LUC2 concentration in the transduction media that would promote long-term, stable 
luciferase expression in primary NP cells.   A concentrated LVE-LUC2 vector (80x 
concentration) was mixed with NP culture media in varying amounts to prepare 
transduction media containing varying viral loads.  Primary porcine NP cells were 
isolated as described in Section 4.2.2, plated at a density of 40,000 cells/cm2 in culture 
media, and cells were allowed to adhere for 24 hours.  Culture media was then aspirated 
from NP cells and replaced with transduction media containing varying amounts of 
concentrated LVE-LUC2 vector (5 –  38.3 µl per ml media supplemented with 4 mg/ml 
polybrene®).  After 24 hours, transduction media was aspirated and fresh culture media 
was added.  Luciferase expressing porcine NP (NP-luc) cells were cultured in monolayer 
(37 °C, 5% CO2, 20% O2) with media changes every 2-3 days and luciferase expression 
was evaluated as described in Section 4.2.3.     
 As expected, luciferase expression in NP cells increased with increasing 
concentrations of LVE-LUC2 vector in the transduction media (Figure 27).  The most 
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stable luciferase expression was observed in cells transduced with the lowest amount of 
LVE-LUC2 vector (5 µl per ml media).  Although this group was also shown to have the 
lowest luciferase expression, long-term stability of reporter gene expression is important 
for longitudinal cell tracking, and therefore this viral load was utilized for subsequent 
organ culture experiments described in Chapter 4.   
 
 
Figure 27. Luciferase activity in cultured porcine NP cells.  NP cells transduced 
with lentivirus encoding for firefly luciferase at varying viral loads (µl concentrated 
LVE-LUC2 per ml media) to assess stability of luciferase expression over time in 
culture.  At each time point, photons per second per cell was calculated from 
measured bioluminescent intensity 10 minutes after addition of luciferin to the media 
(mean ± SEM, n=3).   
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